chloroquine has been researched along with mefloquine in 568 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 121 (21.30) | 18.7374 |
1990's | 176 (30.99) | 18.2507 |
2000's | 127 (22.36) | 29.6817 |
2010's | 125 (22.01) | 24.3611 |
2020's | 19 (3.35) | 2.80 |
Authors | Studies |
---|---|
Alcorn, J; Auschwitz, JM; Das, U; Dimmock, JR; Hickman, MR; Leed, SE; Singh, RS | 1 |
Charman, SA; Chiu, FC; Chollet, J; Dong, Y; Katneni, K; Mannila, J; Morizzi, J; Ryan, E; Santo Tomas, J; Scheurer, C; Snyder, C; Steuten, J; Vennerstrom, JL; Wang, X; Wittlin, S | 1 |
Biamonte, MA; Le Roch, KG; Wanner, J | 1 |
Avery, VM; Sykes, ML | 1 |
Alcorn, J; Das, U; Dimmock, JR; Hickman, MR; Lee, PJ; Leed, SE; Roncal, N; Sciotti, RJ; Singh, RS | 1 |
Azam, A; Inam, A; Leite, AC; Macedo, TS; Moreira, DR; Siddiqui, SM; Soares, MB | 1 |
Avery, VM; Charman, SA; Chibale, K; Douelle, F; Duffy, S; Gonzàlez Cabrera, D; Le Manach, C; March, C; Nchinda, AT; Ryan, E; Street, LJ; Taylor, D; Waterson, D; White, KL; Wiesner, L; Wittlin, S; Witty, MJ; Younis, Y | 1 |
Bavari, S; Burnett, JC; Gomba, L; Konstantinović, J; Krstić, M; Nuss, JE; Opsenica, DM; Sciotti, RJ; Segan, S; Selaković, Z; Solaja, BA; Videnović, M; Zlatović, M | 1 |
Agnamey, P; Azas, N; Cohen, A; Daulouede, S; Del Favero, M; Farvacques, N; Guillon, J; Hutter, S; Le Pape, P; Mullié, C; Pagniez, F; Pinaud, N; Ronga, L; Savrimoutou, S; Sonnet, P; Soum, C; Vincendeau, P | 1 |
Arrendale, RF; Ballie, MT; Bushnev, AS; Culver, DG; Evers, TJ; Galinski, MR; Girard, KR; Holt, JJ; Howard, RB; Lapp, S; Liotta, DC; Menaldino, DS; Meyer, EV; Natchus, MG; Reddy, GP | 1 |
Abla, N; Besson, D; Bombrun, A; Brun, R; Burt, H; Georgi, K; Kaiser, M; Molette, J; Muzerelle, M; Nwaka, S; Routier, J; Scheer, A | 1 |
Avery, VM; Barth, S; Duffy, S; Frank, W; Geffken, D; Held, J; Kamber, J; Kuna, K; Kurz, T; Leven, M; Mordmüller, B; Sax, S; Siethoff, C; Tschan, S; Wittlin, S | 1 |
Blackie, MA; de Kock, C; Hamann, AR; Smith, PJ; van Otterlo, WA | 1 |
Akoto, M; Avery, VM; Duffy, S; Hagen, TJ; Helgren, TR; Igbinoba, O; Lee, P; Sciotti, RJ | 1 |
Bacher, A; Behrendt, C; Brücher, K; Fischer, M; Gräwert, T; Held, J; Illarionov, B; Konzuch, S; Kurz, T; Lienau, C; Maes, L; Mordmüller, B; Wittlin, S | 1 |
Brantner, A; Brun, R; Bucar, F; Faist, J; Gröblacher, B; Kaiser, M; Kalia, Y; Merino, V; Perozzo, R; Saf, R; Scapozza, L; Seebacher, W; Weis, R; Wolkinger, V | 1 |
Barros, MT; Faísca Phillips, AM; Murtinheira, F; Nogueira, F | 1 |
Angulo-Barturen, I; Bashyam, S; Birkholtz, LM; Botha, M; Brunschwig, C; Chibale, K; Churchyard, A; Coetzer, TL; Dhinakaran, R; Ferrer, S; Gonzàlez Cabrera, D; Han, Z; Jiménez-Díaz, MB; Lauterbach, S; Le Manach, C; Meister, S; Njoroge, M; Paquet, T; Reader, J; Santos Martínez, M; Street, LJ; Taylor, D; Waterson, D; Winzeler, EA; Wittlin, S; Witty, MJ | 1 |
Albuquerque, IS; Burojević, J; D'Alessandro, S; Djurković-Djaković, O; Konstantinović, J; Machado, M; Pecic, S; Prudêncio, M; Sciotti, RJ; Šolaja, BA; Srbljanović, J; Štajner, T; Taramelli, D; Terzić, N; Tot, M; Verbić, T; Zlatović, M | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Challal, S; de Queiroz E Silva, DMA; Dos Santos Filho, JM; Macedo, TS; Moreira, DRM; Queiroz, EF; Soares, MBP; Teixeira, HMP; Wolfender, JL | 1 |
Beswick, P; Choowongkomon, K; Chuckowree, I; Gleeson, MP; Hannongbua, S; Horata, N; Obounchoey, P; Phuangsawai, O; Ratanabunyong, S; Srisook, P; Suphakun, P; Tabtimmai, L; Ward, SE | 1 |
Angulo-Barturen, I; Antonova-Koch, Y; Bashyam, S; Birkholtz, LM; Botha, ME; Charman, SA; Chibale, K; Ferrer, S; Gonzàlez Cabrera, D; Han, Z; Jiménez-Díaz, MB; Lawrence, N; Le Manach, C; Martínez, MS; Meister, S; Nchinda, AT; Nondaba, SH; Paquet, T; Reader, J; Street, LJ; Taylor, D; Waterson, D; White, KL; Winzeler, EA; Wittlin, S; Witty, MJ; Younis, Y; Zabiulla, M | 1 |
Araújo, ADS; Barbosa-Lima, G; Bozza, PT; da Silva, ET; de Freitas, CS; de Souza, MVN; Marttorelli, A; Moraes, AM; Neto, JC; Souza, TML; Vieira, YR | 1 |
Avery, VM; Buchholz, M; Delves, MJ; Duffy, S; Fischli, C; Held, J; Knaab, TC; Kuna, K; Kurz, T; Lehmann, U; Leven, M; Lungerich, B; Meister, S; Meitzner, D; Mordmüller, B; Stahlke, P; Winzeler, EA; Wittlin, S | 1 |
Feng, LS; Gao, C; Hu, YQ; Wu, X; Xu, L; Xu, Z; Zhang, S; Zhao, F | 1 |
Boddey, JA; Cowman, AF; Czabotar, PE; de Lezongard, RB; Hodder, AN; Jarman, KE; Jousset Sabroux, H; Nguyen, W; O'Neill, MT; Sleebs, BE; Thompson, JK | 1 |
Chu, XM; Gong, KK; Liang, LL; Liu, W; Sun, KL; Wang, C; Wang, WL | 1 |
Avery, VM; Baell, JB; Ban, K; Beveridge, JG; Blundell, S; Charman, SA; Chavchich, M; Chiu, FCK; Creek, D; Cuellar, ME; Dahlin, JL; Diab, S; Dingjan, T; Duffy, S; Edstein, MD; Ellis, K; Fletcher, S; Harjani, JR; Huang, F; Lucantoni, L; Marfurt, J; Noviyanti, R; Price, RN; Ralph, SA; Shi, DH; Strasser, JM; Teguh, S; Walters, MA; Wirjanata, G; Xue, L | 1 |
Aguiar, ACC; Boechat, N; Carvalho, AS; Coutinho, JP; da Silva, RMRJ; Gandi, MO; Krettli, AU; Mendonça, JS | 1 |
Bane, CE; Black, C; Butler, K; Caridha, D; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Huezo, SJ; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Nolan, C; Olmeda, R; Potter, B; Pou, S; Rasmussen, SA; Read, L; Riscoe, MK; Roncal, N; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Stephens, MT; Tan, JC; Vesely, B; Vuong, C; Winter, RW; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
Azad, CS; Nainwal, LM; Narula, AK | 1 |
Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
Baum, J; Bridgford, JL; Charman, SA; Churchyard, A; Crespo, B; Deni, I; Fidock, DA; Gahalawat, S; Gamo, FJ; Laleu, B; Lawong, A; Mittal, N; Mok, S; Niederstrasser, H; Okombo, J; Palmer, MJ; Phillips, MA; Posner, B; Ready, JM; Striepen, J; Winzeler, E; Wittlin, S; Yeo, T; Zhou, A | 1 |
Augereau, JM; Benoit-Vical, F; Deraeve, C; Jimenez, T; Mustière, R; Nguyen, M; Ouji, M | 1 |
Avery, VM; Challis, MP; Creek, DJ; De Paoli, A; Devine, SM; Kigotho, JK; MacRaild, CA; Norton, RS; Scammells, PJ; Siddiqui, G | 1 |
Agnamey, P; Azas, N; Cohen, A; Damiani, C; Dassonville-Klimpt, A; Dormoi, J; Guillon, J; Marchivie, M; Mullié, C; Pradines, B; Schneider, J; Sonnet, P; Taudon, N; Tisnerat, C; Totet, A | 1 |
Ghosh, SK; Sharma, VP; Yadav, RS | 1 |
Bunnag, D; Chindanond, D; Chittamas, S; Fernex, M; Harinasuta, T; Kristiansen, S; Malikul, S; Mittelholzer, ML; Sturchler, D | 1 |
Adio, RA; Dickschat, U; Mittelholzer, ML; Reber-Liske, R; Salako, LA; Sowunmi, A; Stürchler, D; Walker, O | 1 |
Rodríguez Rey, C | 1 |
Badoual, J | 1 |
Barnes, DA; Cowman, AF; Foote, SJ; Galatis, D; Kemp, DJ | 1 |
Bia, FJ | 1 |
Carbonaro, CA; Horowitz, H | 1 |
Collignon, PJ | 1 |
Brachman, PS; Kozarsky, PE; Metchock, B | 1 |
Bunnag, D; Chitamas, S; Harinasuta, T; Karbwang, J; Viravan, C | 1 |
Fadat, G; Gardon, J; Gazin, P; Hengy, C; Jambou, R; Louis, FJ; Louis, JP; Trebucq, A | 1 |
Cook, GC | 2 |
Bustos, MD; Ciceron, L; Danis, M; Gay, F; Gentilini, M; Pichet, C; Rojas-Rivero, L | 1 |
Currie, PF; Douglas, JG; Green, ST; Nathwani, D; Smith, NC | 1 |
Salako, LA; Sowunmi, A | 1 |
Bauchet, J; Hatin, I; Le Bras, J; Legros, F; Trape, JF | 1 |
Basco, LK; Bouchaud, O; Coulaud, JP; Farinotti, R; Gillotin, C; Gimenez, F; Le Bras, J; Rabenjarson, E; Ringwald, P | 1 |
Akintonwa, A; Orisakwe, OE | 1 |
Baudon, D; Cordoliani, G; Da Conceicao, S; Delolme, H; Doury, JC; Hovette, P; Lecamus, JL; Martet, G; Raphenon, G; Touze, JE | 1 |
Allaouchiche, B; Biron, F; Boibieux, A; Gaussorgues, P; Gerard-Boncompain, M; Peyramond, D; Robert, D; Salord, F; Sirodot, M | 1 |
Thomas, JE | 1 |
Trigg, PI | 1 |
Bocquet, JP; Taillan, F | 1 |
Carme, B | 1 |
Baird, JK; Bangs, MJ; Basri, H; Jones, TR; Ritonga, A | 1 |
Broderson, JR; Collins, WE; Ma, NS; Richardson, BB; Skinner, JC; Stanfill, PS | 1 |
Bergqvist, Y; Hellgren, U; Kihamia, CM; Rombo, L | 1 |
Ayivi, B; Bégué, P; Quinet, B; Ter Sakarian, M | 1 |
Boudreau, EF; Chaikummao, S; Pang, LW; Witayarut, C | 1 |
Bloland, P; Campbell, CC; Howell, BJ; Lackritz, EM; Lobel, HO | 1 |
Abua, JU; Lege-Oguntoye, L; Ogala, WN; Olurinola, PF; Slotboom, AB; Werblinska, B | 1 |
Sugioka, Y; Suzuki, M | 1 |
Brandicourt, O; Carme, B; Gay, F; Gentilini, M; Turk, P | 1 |
Bourdeau, EF; Childs, GE; Milhous, WK; Pang, L; Wimonwattratee, T | 1 |
Le Bras, M; Mazaudier, E; Raccurt, CP; Ripert, C; Schmitt, A | 1 |
Chakrabarti, NK; Nagaraj, C; Narasimham, MV | 1 |
Berger, M; Beytout, J; Cambon, M; Rey, M; Ringwald, P | 1 |
Hopfenmüller, W; Janitschke, K; Schultes, U; Weber, G; Weinke, T | 1 |
Bustos, MD; Danis, M; Diquet, B; Félix, R; Gay, F; Gentilini, M; Lyogoubi, A | 1 |
Eberlé, F; Gazin, P; Gelas, H; Hengy, C; Jambou, R; Kouka-Bemba, D | 1 |
Dutt, SC; Karmakar, P; Narasimham, MV; Sharma, RC | 1 |
Allen, MA; Bell, CA; Grogl, M; Hall, JE; Kyle, DE; Ohemeng, KA; Tidwell, RR | 1 |
Brandicourt, O; Carme, B; Gay, F; Gentilini, M; Le Bras, J; Mbitsi, A; Moudzeo, H; Ndounga, M; Sathounkazi, C | 1 |
Akogbeto, M; Chippaux, JP; Josse, R; Massougbodji, A; Sadeler, BC; Zohoun, T | 1 |
Broderson, JR; Collins, WE; Filipski, VK; Morris, CL; Ruebush, TK; Skinner, JC; Stanfill, PS | 1 |
Le Bras, J; Malhotra, K; Salmon, D; Vilde, JL | 1 |
De Boeck, H; Maguire, PA; Sherman, IW; Zidovetzki, R | 1 |
Go, ML; Lee, HS | 1 |
Andersen, BJ; Bygbjerg, IC; Pedersen, BK; Theander, TG | 1 |
Breckenridge, A | 1 |
Lapierre, J; Périn, M; Sureau, C | 1 |
Boudreau, EF; Childs, GE; Davidson, DE; Milhous, WK; Pang, L; Pooyindee, N; Wimonwattratee, T | 1 |
Afshar, A; Edrissian, GH; Emadi, AM; Ghorbani, M; Kanani, A; Mohsseni, G; Nasseri-Nejad, K; Satvat, MT | 1 |
Caligaris, S; Carosi, G; Castelli, F; Druilhe, P; Olliaro, P | 1 |
Abissègue, B; Garrigue, G; Gazin, P; Gelas, H; Ghogomu, NA; Hengy, C; Jambou, R; Kouka-Bemba, D; Le Bras, J | 1 |
Davis, DR; Lambros, C; Lewis, GE | 1 |
Chandrahas, RK; Choudhury, DS; Ghosh, SK; Ramanaiah, TV; Sharma, VP; Singh, N | 1 |
Gao, DQ; Liu, DQ; Liu, RJ; Qiu, CP; Ren, DX | 1 |
Andriamangatiana-Rason, MD; Coulanges, P; Deloron, P; Lepers, JP; Ramanamirija, JA | 1 |
Edrissian, GH | 1 |
Atiya, A; De Boeck, H; Sherman, IW; Zidovetzki, R | 1 |
Aderounmu, AF; Salako, LA; Simooya, OO | 1 |
Aina Adio, R; Fadeke Aderounmu, A; Laoye, AJ; Modupe Makinde, J; Salako, LA | 1 |
Bunnag, D; Harinasuta, T; Lasserre, R; Leimer, R; Vinijanont, S | 1 |
Diquet, B; Djibo, L; Druilhe, P; Felix, H; Jacquier, P | 1 |
Fadeke Aderounmu, A; Salako, LA | 1 |
Bunnag, D; Chittamas, S; Harinasuta, T; Looareesuwan, S; White, NJ | 1 |
Kollaritsch, H; Kollaritsch, R; Kremsner, P; Leimer, R; Mailer, H; Stemberger, H; Wiedermann, G | 1 |
Lwin, M; Zaw, M | 1 |
Walter, RD | 1 |
Bonnevie, O; Cordoliani, G; Dedet, JP; Germanetto, P; Le Bras, J | 1 |
Denis, MB; Giboda, M | 1 |
Brandicourt, O; Brasseur, P; Druilhe, P; Kouamouo, J; Moyou-Somo, R | 1 |
Bastien, P; Gentilini, M; Saliou, P | 1 |
Ihrahim, AM | 1 |
Brubaker, G; Draper, CC; Hills, M; Kilimali, VA | 1 |
Ali, S; Björkman, A; Lebbad, M; Warsame, M; Wernsdorfer, WH | 1 |
Druilhe, P; Gentilini, M; Stahel, E | 1 |
Kightlinger, LK; Kightlinger, MB | 1 |
Alpers, MP; Brabin, BJ; Eggelte, T; Klever, HJ; van der Kaay, HJ; Witte, AM | 1 |
Aderounmu, AF; Adio, RA; Laoye, JO; Makinde, JM; Salako, LA | 1 |
Bouchara, JP; Chabasse, D; De Gentile, L; Le Bras, J; Ligny, C; Rialland, X | 1 |
Rolfe, M | 1 |
Bellesi, N; Couto, AA; de Oliveira, SG; do Rosário, VE; Santos, MA | 1 |
Chanthavanich, P; Karbwang, J; Looareesuwan, S; Phillips, RE; Supanaranond, W; Turner, RC; Warrell, DA; White, NJ | 1 |
Ayub, M; Scott, TA | 1 |
Prapunwattana, P; Vanderkooi, G; Yuthavong, Y | 1 |
Babin-Chevaye, C; Labro, MT | 1 |
Chaumont, AJ; Kintz, P; Lamant, JM; Lugnier, AA; Mangin, P; Tracqui, A | 1 |
Childs, GE; Pooyindee, N; Wimonwattrawatee, T | 1 |
Boudreau, EF; Chen, C; Childs, GE; Häusler, B; Milhous, W; Pooyindee, N; Wimonwattrawatee, T | 1 |
Bugilimfura, L; Deloron, P; Neill, M; Ntilivamunda, A; Sexton, JD | 1 |
Ginsburg, H; Krugliak, M | 1 |
Burchard, GD; Winkler, E | 1 |
Björkman, A; Willcox, M | 1 |
Attanath, P; Chantavanich, P; Chongsuphajaisiddhi, T; Sabchareon, A; Sheth, UK; Singhasivanon, V; Wernsdorfer, WH | 1 |
Ho, KB; Mak, JW; Ramadas, M | 1 |
Long, GW; Mama, S; Ranoa, CP; Sangalang, RP; Sy, N | 1 |
Buck, RL; Long, GW; Ranoa, CP; Sangalang, RP; Sy, N; Watt, G | 1 |
Brockelman, CR; Bunnag, D; Satayavivad, J; Tan-ariya, P; Wongsawatkul, O | 1 |
Charmot, G; Le Bras, J; Simon, F | 1 |
Biaud, JM; Calmel, MB; Clausse, JL; Deloron, P; Hatin, I; Le Bras, J; Marchais, H; Porte, J; Ramanamirija, JA; Simon, F | 1 |
Fox, E; Khaliq, AA; Sarwar, M; Strickland, GT | 1 |
Huang, QL; Wu, Z; Zhang, KY; Zhou, JX | 1 |
Kuhlow, F; Walter, RD; Wittich, RM | 1 |
Bendtzen, K; Bygbjerg, IC; Svenson, M; Theander, TG | 1 |
Armstead, A; Campbell, CC; Collins, WE; Milhous, WK; Roberts, JM | 1 |
Brandicourt, O; Brasseur, P; Danis, M; Druilhe, P; Kouamouo, J; Moyou, SR | 1 |
Ginsburg, H; Krugliak, M; Zarchin, S | 1 |
Denis, MB | 1 |
Andersen, BJ; Bygbjerg, IC; Flachs, H; Jepsen, S; Larsen, PB; Theander, TG | 1 |
Bonanni, LC; Geary, TG; Ginsburg, H; Jensen, JB | 1 |
Bhattacharya, DN; Hall, AP | 1 |
Brandicourt, O; Brasseur, P; Danis, M; Diouf, F; Druilhe, P; Gay, F; Kombila, MY; Kouamouo, J; Moyou, RS; Richard-Lenoble, D | 1 |
Delacollette, C; Hendrix, L; Mpungu, MT; Ngimbi, NP; Wery, M | 1 |
Liu, DQ; Liu, RJ; Qiu, CP; Ren, DX | 1 |
Rathaur, S; Walter, RD | 1 |
Gajanana, A; Sinha, S; Vasisth, S | 1 |
Back, DJ; Karbwang, J; Looareesuwan, S; Molyneux, ME; Nagachinta, B; Phillips, RE; Warrell, DA; Wattanagoon, Y | 1 |
Glasner, H; Landscheidt, H; Niklewski, G | 1 |
Alexander, BM; Bowdre, JH; Desjardins, RE; Oduola, AM; Weatherly, NF | 1 |
Boudreau, EF; Pang, LW; Pavanand, K; Webster, HK; Yongvanitchit, K | 1 |
Alcantara, AK; Buck, RL; Rodriguez, CS; Smrkovski, LL; Uylangco, CV | 1 |
Dixon, KE; Phintuyothin, P; Pitaktong, U | 1 |
Peters, W | 1 |
Arias, AE; Cortes, GT; Espinal, CA; Guerra, P | 1 |
Canfield, CJ; Cosgriff, TM; Pamplin, CL; Willet, GP | 1 |
Gluzman, IY; Krogstad, DJ; Schlesinger, PH | 1 |
Nguyen-Dinh, P | 1 |
Delacollette, C; Gregory, MG; Mpungu, MT; Ngimbi, NP; Wery, M | 1 |
Froeling, FM; Van der Kaay, HJ; Wernsdorfer, WH | 1 |
Coulanges, P; Deloron, P; Le Bras, J; Ramanamirija, JA | 1 |
Charmot, G; Dupont, B; Lapresle, C; Le Bras, J; Sansonetti, P | 1 |
Li, GD | 1 |
Hogerzeil, HV; Hogewoning, AA; van der Kaay, HJ; van Doorn, JW; Wernsdorfer, WH | 1 |
Danis, M; Gentilini, M | 1 |
Salako, LA | 1 |
Alcantara, AK; Cross, JH; Sangalang, RP; Uylangco, CV | 1 |
Bruce-Chwatt, LJ | 1 |
Mrema, JE; Rieckmann, KH | 1 |
Demel, RA; Ginsburg, H | 1 |
Ferrante, A; Goh, DH | 1 |
Deloron, P; Le Bras, J | 1 |
Bunnag, D; Harinasuta, T; Wernsdorfer, WH | 1 |
Beale, GH; Chutmongkonkul, M; Thaithong, S | 1 |
Andrieu, B; Coulaud, JP; Deloron, P; Le Bras, J; Ricour, A; Savel, J | 1 |
Kofi Ekue, JM; Rwabwogo-Atenyi, J; Sheth, UK; Ulrich, AM | 1 |
Prüfer, L; von Sonnenburg, F | 1 |
Burchard, GD; Dietrich, M; Horstmann, RD; Wernsdorfer, WH | 1 |
Chiodini, PL; Ellis, CJ | 1 |
Alpers, MP; Davidson, WL; Jolley, D; Knowles, G | 1 |
Coulanges, P; Deloron, P; Dourado, HV; Hartmann, JF; Larouze, B; Le Bras, J | 1 |
Bendle, MS; Das, M; Dutt, SC; Karmakar, P; Sharma, GK | 1 |
Rosário, VE; Vasconcelos, MA | 1 |
Akood, MA; Carlin, JM; Jensen, JB; Vande Waa, JA | 1 |
Coulanges, P; Coulaud, JP; Deloron, P; Le Bras, J | 1 |
Königk, E; Putfarken, B | 1 |
Dutta, P; Fitch, CD | 1 |
Andrieu, B; Deloron, P; Hartmann, JF; Le Bras, J | 1 |
Childs, GE; Davidson, DE; Klayman, DL; Lambros, C; Notsch, JD; Scovill, JP | 1 |
Abdel-Rasoul, S; Königk, E; Mirtsch, S; Putfarken, B | 1 |
Dutta, GP; Singh, PP | 1 |
Merkli, B; Peters, W; Richle, R | 1 |
Govitrapong, P; Jearnpipatkul, A; Panijpan, B; Wilairat, P; Yuthavong, Y | 1 |
Brockelman, CR; Monkolkeha, S; Tanariya, P | 1 |
Fernex, M | 1 |
Abdalla, RE; El Gaddal, AA; Kouznetsov, RL; Payne, D; Rooney, W; Wernsdorfer, WH | 1 |
Howells, RE; Judge, BM | 1 |
Sweeney, TR | 1 |
Alvar, J; Amela, C; Benito, A; Molina, R; Roche, J | 1 |
Crevoisier, C; Mittelholzer, ML; Peters, W; Robinson, BL; Stürchler, D | 1 |
Grisolia, CK; Takahashi, CS | 1 |
Lench, P | 1 |
Eichenlaub, D; Jelinek, T; Löscher, T; Schelbert, P | 1 |
Del Nero, L; Lamizana, L; Nebié, I; Pietra, V | 2 |
Knobloch, J | 1 |
Croft, A | 1 |
Deacon, HE; Freese, JA; Sharp, BL | 1 |
Hoffman, SL; Johnson, A; Koech, D; Oloo, AJ; Weiss, WR | 1 |
Armengaud, M; Piccoli, S; Picot, N | 1 |
Basco, LK; Le Bras, J; Makler, MM; Marquet, F | 1 |
Calvert, L; Raeside, F; Walker, E | 1 |
Chatnugrob, P; Eamsila, C; Lasserre, R; Mittelholzer, ML; Nopavong Na Ayuthya, A; Singharaj, P; Stürchler, D; Webster, HK; Yooyen, P | 1 |
Yang, H; Yang, P; Yang, Y | 1 |
Edwards, G; Ward, SA; Winstanley, PA | 1 |
Baric, RS; Bright, P; Handy, J; Peel, SA; Yount, B | 1 |
Aouba, A; Guiguemde, TR; Lamizana, L; Ouedraogo, JB | 1 |
Hovette, P; Martet, G; Merouze, F; Nicolas, P; Touze, JE | 1 |
Basco, LK; Le Bras, J | 3 |
Bailey D [corrected to Bradley, D]; Bradley, D; Warhurst, D | 1 |
Casassus, P; Danis, M; Datry, A; Felix, H; Gay, F; Gentilini, M; Lortholary, O | 1 |
Huber, W; Hurt, N; Jaquet, C; Koella, JC; Mshinda, H; Tanner, M | 1 |
Cowman, AF; Karcz, S | 1 |
Bernard, KW; Campbell, CC; Eng, T; Hightower, AW; Lobel, HO; Miani, M | 1 |
DeFraites, RF; Hanson, RK; Sánchez, JL; Sharp, TW | 1 |
Fuchs, E; Funk, M; Naef, U; Nevill, C; Phillips-Howard, P; Schildknecht, J; Schlagenhauf, P; Steffen, R; Stürchler, D | 1 |
Allard, R; Gyorkos, TW; Milord, F | 1 |
Held, TK; Mansmann, U; Pohle, HD; Trautmann, M; Weinke, T | 1 |
Luxemburger, C; Nosten, F; ter Kuile, FO; White, NJ | 1 |
Basco, LK; Le Bras, J; Ramiliarisoa, O | 1 |
Aoki, M; Kamei, K; Miyashita, T; Nishiya, H; Ohyatsu, I; Ono, Y; Shibuya, T; Sugiyama, H; Tokumura, Y; Yamaguchi, M | 1 |
Fowler, VG; Irare, SG; Lemnge, M; Malecela, E; Mashaka, M; Mhina, J; Mtoi, R; Mtui, S | 1 |
Boudreau, E; Dausel, L; Hanson, R; Johnson, R; Novakowski, W; Redmond, D; Sanchez, J; Schuster, B | 1 |
Baily, G; Dunbar, EM; Fraser, IS; Wilkins, EG | 1 |
Smart, A; Walters, L | 1 |
Bray, PG; Howells, RE; Ndifor, AM; Ngu, JL; Ward, SA | 1 |
Davis, DR; Hutton, DC; Rieckmann, KH; Simpson, R; Wheatley, PF; Yeo, AE | 1 |
Ager, AL; Canfield, CJ; Heiffer, MH; Klayman, DL; Kyle, DE; Milhous, WK; Rossan, RN; Schuster, BG; Shmuklarsky, MJ; Tang, DB | 1 |
Baric, RS; Handy, J; Merritt, SC; Peel, SA | 1 |
Schubarth, P | 1 |
Bradley, D | 1 |
Gerena, L; Karle, JM; Milhous, WK; Olmeda, R | 1 |
Bendtzen, K; Jakobsen, PH; Staalsø, T; Stürchler, D | 1 |
Alin, MH; Ashton, M; Bjorkman, A; Bwijo, BA; Kihamia, CM; Mtey, GJ; Premji, Z | 1 |
Batchelor, R; Burans, JP; Iriye, C; Lobel, HO; Longer, CF; Magill, AJ; Rozmajzl, P; Sharp, TW; Smoak, B; Thornton, SA; Wallace, MR | 1 |
Evans, SG; Havlik, I | 1 |
Basco, LK; de Pecoulas, PE; Le Bras, J; Wilson, CM | 1 |
Breman, JG; Heymann, DL; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
Breman, JG; Heymann, DL; Khoromana, CO; Roberts, JM; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
Breman, JG; Heymann, DL; Hightower, AW; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
Breman, JG; Heymann, DL; Khoromana, CO; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
Breman, JG; Heymann, DL; Khoromana, CO; Slutsker, WL; Steketee, RW; Wirima, JJ | 1 |
Basco, LK; Le Bras, J; Rhoades, Z; Wilson, CM | 1 |
Diallo, S; Dieng, B; Faye, B; Faye, C; Faye, O; Gaye, O; N'Dir, O | 1 |
Barrett, PJ; Bradley, DJ; Clarke, PD; Emmins, PD | 1 |
Bouquety, JC; Carme, B; Gay, F; Hayette-Gorremans, MP; Ndounga, M | 1 |
Chung, R; Cowman, AF; Foley, M; Riffkin, CD; Tilley, L; Wall, DM; Zalcberg, JR | 1 |
Behrens, RH; Corbett, EL; Doherty, JP | 1 |
Dollow, S | 1 |
Bray, PG; Green, JE; Hawley, SR; Mungthin, M; Ritchie, GY; Ward, SA | 1 |
Adak, T; Ansari, MA; Biswas, S; Devi, CU; Pillai, CR; Sharma, YD | 1 |
Heppner, DG; Kawamoto, F; Nguyen, TD; Sookto, P; Trieu, NT; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
Foley, M; Tilley, L | 1 |
Fleck, SL; Peters, W; Robinson, BL | 1 |
Bosje, T; Luinstra-Passchier, MJ; Wolters, BA | 1 |
Alin, MH | 1 |
Croft, SL; Elueze, EI; Warhurst, DC | 1 |
de Beer, PA | 1 |
Caparrós, F; Codina, C; Corachán, M; Corominas, N; Gascón, J; Mejías, T; Quintó, L; Ribas, J | 1 |
Carme, B; Nevez, G; Peguet, C | 2 |
Kozarsky, PE; Lobel, HO | 1 |
Aung, H; Aung, S; Kyaw, MP; Lwin, M; Oo, H; Sint, N; Thein, H; Tun, SM; Win, Y | 1 |
Adagu, IS; Machado, RL; Miles, MA; Oliveira, SG; Póvoa, MM; Warhurst, DC | 1 |
Ellis, CJ | 1 |
Boele van Hensbroek, M; Kager, PA; Wetsteyn, JC; Zijlmans, CW | 1 |
Doury, JC; Fusai, T; Pradines, B; Rogier, C; Tall, A; Trape, JF | 1 |
Chene, L; Chongsuphajaisiddhi, T; Daubersies, P; Druilhe, P; Gentil, C; Langsley, G; Mellouk, S; Patarapotikul, J | 1 |
Schwartz, E; Sidi, Y | 1 |
Kremsner, PG; Philipps, J; Radloff, PD; Wernsdorfer, W | 1 |
Behrens, RH; Bradley, D; Reyburn, H; Warhurst, D | 1 |
Jelinek, T; Muehlberger, N; Nothdurft, HD; Schlipkoeter, U; von Sonnenburg, F | 1 |
Coulibaly, SO; Dutheil, Y; Guiguemdé, TR; Ouédraogo, JB; Tall, F; Tinto, H; Traoré, B; Zampa, H | 1 |
Erny, S; Maradit, H | 1 |
Blanco García, A; de Górgolas Hernández-Mora, M; Fernández Guerrero, ML; Martín Torres, MP | 1 |
Volkman, S; Wirth, D | 1 |
Edwards, R; Fuchs, E; Kerr, L; Phillips-Howard, PA; Schildknecht, J; Steffen, R; Vanhauwere, B | 1 |
di Piazza, JP; Durand, R; Le Bras, J; Longuet, C; Parzy, D; Pradines, B | 1 |
Davis, TM | 1 |
Bray, PG; Mungthin, M; Ridley, RG; Ward, SA | 1 |
Ang, HH; Chan, KL; Mak, JW | 1 |
Goldberg, DE; Matile, H; Ridley, RG; Sullivan, DJ | 1 |
Ayles, HM; Behrens, RH; Bovill, BA; Bryceson, AD; Felton, JM; Jennings, RM; Mabey, DC; Reid, AJ; Whitty, CJ | 1 |
Berger, A | 1 |
Kvern, BL; Lysack, CL; Lysack, JT | 1 |
Dande, PA; Dorn, A; Ellis, WY; Gerena, L; Milhous, WK; Miller, RE; Nuzum, EO; Ridley, RG; Vennerstrom, JL | 1 |
Bourgeade, A; Delmont, J | 1 |
Burgel, PR; Camara, P; Hovette, P; Klotz, F; Mbaye, PS; Sane, M | 1 |
Whitty, CJ | 1 |
Aung, S; Ejov, MN; Sein, K; Tun, T | 1 |
Le Bras, J | 1 |
Juckett, G | 1 |
White, N | 1 |
Alaribe, AA; Chukwuani, CM; Ekanem, OJ; Ezedinachi, EN; Haller, L; Meremikwu, MM; Ojar, EA; Umotong, AB | 1 |
Suzuki, M | 1 |
Buckling, A; Crooks, L; Read, A | 1 |
Bray, PG; Mungthin, M; Ward, SA | 1 |
Danis, M; Delhaes, L; Gay, F; Lazaro, JE; Thellier, M | 1 |
Botella de Maglia, J; Espacio Casanovas, A | 1 |
Clerinx, J; De Paep, R; Van den Ende, J | 1 |
Angkasekwinai, P; Buranakiti, A; Chaiyaroj, SC; Cowman, AF; Looressuwan, S | 1 |
Duraisingh, MT; Jones, P; Pinder, M; Sambou, I; von Seidlein, L; Warhurst, DC | 1 |
Elford, BC; Ginsburg, H; Krugliak, M; Lew, VL; Tiffert, T | 1 |
Caruana, SR; Cowman, AF; Kirk, K; Reed, MB; Saliba, KJ | 1 |
Auparakkitanon, S; Chavalitshewinkoon-Petmitr, P; Pongvilairat, G; Wilairat, P | 1 |
Makonnen, E; Mengesha, T | 1 |
Contini, C; Cultrera, R | 1 |
Behrens, RH; Day, JH; Evans, MR | 1 |
Dalvi, SS; Gogtay, NJ; Kshirsagar, NA; Rajgor, D; Wakde, M | 1 |
Myrvang, B | 1 |
Blystad, H | 1 |
Hombhanje, FW | 1 |
Bachhawat, K; Surolia, A; Surolia, N; Thomas, CJ | 1 |
Saul, A | 1 |
Bloland, PB; Ettling, M; Meek, S | 1 |
Collins, WE; Fryauff, DJ; Galland, GG; Jennings, V; Kendall, J; Morris, CL; Sullivan, JS | 1 |
Corry, A; Fitzmaurice, L; Jackson, MA; Kearns, GL; Lowry, JA | 1 |
Bhagwat, AN; Bhatt, R; Godse, C; Joshi, J; Vaidya, AD; Vaidya, RA | 1 |
Brandts, C; Kremsner, PG; Philipps, J; Schwenke, A; Wernsdorfer, WH; Winkler, S | 1 |
Kramer, MH; Lobel, HO | 1 |
Ariey, F; Jambou, R; Raharimalala, LA; Randrianarivelojosia, M; Randrianasolo, L; Rason, MA; Ratsimbasoa, A | 1 |
Brasseur, P; Cuzin-Ouattara, N; Druilhe, P; Moreno, A; Nebie, I; Sanon, S | 1 |
Kain, KC; Keystone, JS; Shanks, GD | 1 |
Bauer, J; Burchard, GD | 1 |
Beck, B; Blum, J; Funk, M; Furrer, H; Genton, B; Hatz, FR; Holzer, B; Loutan, L; Markwalder, K; Raeber, PA; Schlagenhauf, P; Siegl, G; Steffen, R; Stürchler, D; Wyss, R | 1 |
Angenot, L; De Mol, P; Frédérich, M; Hayette, MP; Tits, M | 1 |
Kaye, D | 1 |
Cravo, P; Culleton, R; Hunt, P; Mackinnon, MJ; Walliker, D | 1 |
Peragallo, MS | 1 |
Croft, AM; Geary, KG | 1 |
Faiz, MA; Kawamoto, F; Laoboonchai, A; Lin, K; Noedl, H; Pang, LW; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
World, MJ | 1 |
Kollaritsch, H; Krudsood, S; Looareesuwan, S; Noedl, H; Viriyavejakul, P; Wernsdorfer, WH; Wiedermann, G; Wilairatana, P | 1 |
Famin, O; Ginsburg, H | 1 |
Kyle, DE; Milhous, WK; Riel, MA | 1 |
Gerena, L; Guan, J; Kyle, DE; Lin, AJ; Milhous, WK; Zhang, Q | 1 |
Belsare, H; Patel, AB | 1 |
Odenholt, I; Petersson, H; Rietz, G | 1 |
Jong, EC; Nothdurft, HD | 1 |
Ameisen, JC; Coppin, A; DeBels, F; Dewailly, E; Dzierszinski, F; Mortuaire, M; Slomianny, C; Tomavo, S | 1 |
Andrews, C; Richens, A | 1 |
Fidock, DA; Sidhu, AB; Verdier-Pinard, D | 1 |
Agrawal, R; Dutta, GP; Jain, SK; Shukla, OP; Tekwani, BL; Tripathi, R | 1 |
Cravo, P; do Rosário, VE; Gil, JP; Lopes, D; Nogueira, F; Rungsihirunrat, K; Seugorn, A | 1 |
Coley, AM; Fadden, P; Foley, M; Graves, PR; Hardeman, K; Haystead, TA; Kwiek, JJ; Ray, R | 1 |
Al-Aniezi, A; Hira, PR; Lqbal, J; Sher, A | 1 |
Atteke, C; Aubouy, A; Bakary, M; Deloron, P; Lébibi, J; Ndong, JM | 1 |
Arróspide, N; Arrunátegui, M; Barat, LM; Cabezas, C; Carrillo, C; Chafloque, ML; Garavito, G; Gutierrez, S; MacArthur, JR; Marquiño, W; Oblitas, FE; Pardavé, B; Ruebush, TK | 1 |
Huang, K; Liao, M; Liu, D; Yang, H; Yang, P; Yang, Y; Zhang, C | 1 |
Bouchaud, O; Durand, R; Godineau, N; Jezic, Z; Keundjian, A; Le Bras, J; Pradines, B; Ralaimazava, P | 1 |
Jambou, R; Randrianarijaona, A; Randrianarivelojosia, M; Randrianasolo, L; Ratsimbasoa, A | 1 |
Faiz, MA; Hossain, MA; Miller, RS; Noedl, H; Pang, LW; Rahman, MR; Samad, R; Wongsrichanalai, C; Yunus, EB | 1 |
Ariey, F; Duchemin, JB; Harisoa, JL; Mauclere, P; Pietra, V; Rabarijaona, LP; Raharimalala, LA; Rakotomanana, F; Ranaivo, L; Randrianarivelojosia, M; Robert, V | 1 |
Pfeifer, C; Strauss, R | 1 |
Diarra, A; Konate, A; Moran, AC; Newman, RD; Parise, ME; Sawadogo, R; Sirima, SB; Yameogo, M | 1 |
Hoelscher, M; Löscher, T | 1 |
Peters, W; Robinson, BL; Stewart, LB | 1 |
Munasinghe, A; Myrick, A; Patankar, S; Wirth, DF | 1 |
Beer, MD; Cook, GC; Croft, AM; Whitehouse, DP | 1 |
Fateye, BA; Sowunmi, A | 1 |
Ayomi, E; Baird, JK; Bangs, MJ; Barcus, MJ; Basri, H; Elyazar, IR; Fryauff, DJ; Marwoto, H; Richie, TL | 1 |
Cetron, M; Kozarsky, P; Parise, M; Schwartz, E | 1 |
Fischer, PR; Stauffer, W | 1 |
Dalvi, SS; Desai, S; Gogtay, NJ; Kadam, VS; Kamtekar, KD; Kshirsagar, NA | 1 |
Chambers, JA | 1 |
Hayton, K; Su, XZ | 1 |
Alecrim, WD; Daniel-Ribeiro, CT; Martínez-Espinosa, FE | 1 |
Brown, ML; Geyer, JA; Terrell, JC; Trotta, RF | 1 |
Hatabu, T; Kano, S; Kawazu, S; Rivera, PT; Suzuki, J; Suzuki, M; Valenzuela, RF; Villacorte, EA | 1 |
Garcia, C; Gerena, L; Huaman, MC; Kanbara, H; Long, TT; Magill, AJ; Nakazawa, S; Roncal, N; Solari, L | 1 |
Egan, J; Hoppe, HC; Meredith, SA; van Schalkwyk, DA; Weber, BW; Wiehart, UI | 1 |
Chibale, K; Gut, J; Lehman, J; Musonda, CC; Rosenthal, PJ; Taylor, D | 1 |
Chim, P; Fandeur, T; Lim, P; Maciejewski, L; Nhem, S; Sem, R | 1 |
Majori, G | 1 |
Emerson, LR; Kuchler, K; Skillman, BC; Wirth, DF; Wolfger, H | 1 |
Stingl, P | 1 |
Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
Litmanovich, M; Storch, S; Weiner, P; Zamir, C; Zamir, D | 1 |
Kyaw, MK; Lwin, S; Savran, O; Shahmanesh, M; Smithuis, F; White, NJ | 1 |
Croft, AM | 4 |
Chim, P; Denis, MB; Fandeur, T; Lim, C; Lim, P; Nemh, S; Poravuth, Y; Seila, S; Sem, R; Socheat, D; Tsuyuoka, R | 1 |
Bouchaud, O; Cha, O; Coulaud, JP; Durand, R; Fontanet, AL; Houzé, S; Keundjian, A; Le Bras, J; Ralaimazava, P; Schiemann, R | 1 |
Brega, S; Cheminel, V; de Monbrison, F; Gérôme, P; Peyron, F; Picot, S; Velut, G | 1 |
Daga, SR; Patil, VB; Verma, B | 1 |
Adams, B; Elandalloussi, LM; Smith, PJ | 1 |
Baird, JK | 1 |
Bualombai, P; Congpuong, K; Mungthin, M; Na Bangchang, K; Wernsdorfer, WH | 1 |
Bangchang, KN; Chaijaroenkul, W; Mungthin, M; Ward, SA | 1 |
Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
Garner, P; Jones, K; Taylor-Robinson, D | 1 |
Petersen, JE | 1 |
Kurtzhals, JA; Vestergaard, LS | 1 |
Krishna, S; Uhlemann, AC | 1 |
Baruah, S; Campbell, P; Narain, K; Rogers, CC | 1 |
Hatabu, T; Kano, S; Kawazu, S; Kojima, S; Looareesuwan, S; Sato, K; Singhasivanon, P | 1 |
Carmona-Fonseca, J; Guzmán, V | 1 |
Baird, JK; Fryauff, DJ; Maguire, JD; Marwoto, H; Richie, TL | 1 |
Krishna, S; Woodrow, CJ | 1 |
Lee, HY; Tan, CH; Tor, PC | 1 |
Faragalla, IA; Mohamadani, AA; Nour, BY; Saeed, OK | 1 |
Handforth, A; Martin, FC | 1 |
Alisky, JM; Chertkova, EL; Iczkowski, KA | 1 |
A'shikin, AN; Khairul, MF; Low, JH; Min, TH; Nasriyyah, CH; Norazmi, MN; Raju, SS; Ravichandran, M | 1 |
Andrews, KT; Gardiner, DL; McCarthy, J; Melville, L; Skinner-Adams, TS | 1 |
A'shikin, AN; Che Nasriyyah, CH; Khairul, MF; Low, JH; Min, TH; Norazmi, MN; Raju, SS; Ravichandran, M | 1 |
Aydin, K; Ergüven, S; Ozkaya, G; Unal, S; Yildirim, T | 1 |
Brockman, A; Chotivanich, K; Day, NP; Stepniewska, K; White, NJ | 1 |
Congpuong, K; Na-Bangchang, K | 1 |
Anderson, T; Barends, M; Brockman, A; Jaidee, A; Mayxay, M; Nair, S; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Sudimack, D; White, NJ | 1 |
Deharo, E; Garavito, G; Maurel, S; Monje, MC; Nepveu, F; Valentin, A | 1 |
Lochner, M; Lummis, SC; Thompson, AJ | 1 |
Abuaku, B; Duah, NO; Koram, KA; Quashie, NB | 1 |
Andrianantenaina, HB; Ariey, F; Domarle, O; Randrianarivelojosia, M; Rason, MA; Raveloson, A | 1 |
Aubouy, A; Bertin, G; Deloron, P; Fievet, N; Kinde-Gazard, D; Kiniffo, R; Kossou, H; Massougbodji, A; Sagbo, JC | 1 |
Barnwell, JW; Bounngaseng, A; Collins, WE; Galland, GG; Grady, KK; Hall, P; Huber, C; Nace, D; Ruebush, TK; Sullivan, JJ; Sullivan, JS; Williams, A; Williams, T | 1 |
Blair, S; Carmona, J; Maestre, A; Montoya, P; Tobón, A | 1 |
Nyunt, MM; Plowe, CV | 1 |
Clark, SL; Crawford, P; Nichols, W; Reamy, BV | 1 |
Congpuong, K; Rojanawatsirivet, C; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH; Woitsch, B | 1 |
Bissagnene, E; Die-Kakou, H; Jansen, FH; Lesaffre, E; Penali, LK; Zattera, MJ | 1 |
Crawford, P; Hayes, M; Nichols, W; Wiltz, SA | 1 |
Stepniewska, K; White, NJ | 1 |
Lummis, SC; Thompson, AJ | 1 |
Egan, TJ; Hoppe, HC; Joiner, KA; Roberts, L | 1 |
Ahmadi, M; El-Bahnasawy, M; Gouda, H; Ibrahim, A; Shahat, SA; Zaher, T | 1 |
Arango, E; Cravo, P; Do Rosário, VE; Maestre, A; Restrepo-Pineda, E | 1 |
Amalvict, R; Baret, E; Briolant, S; Fontaine, A; Fraisse, L; Fusaï, T; Henry, M; Mosnier, J; Pradines, B; Rogier, C | 1 |
Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B | 1 |
Ariey, F; Chim, P; Lim, P; Muth, S; Rogers, WO; Sem, R; Socheat, D; Tero, T; Wongsrichanalai, C | 1 |
Co, EM; Dennull, RA; Johnson, JD; Reinbold, DD; Waters, NC | 1 |
Chaijaroenkul, W; Harnyuttanakorn, P; Mungthin, M; Na Bangchang, K; Suwandittakul, N | 1 |
Croft, AM; Jacquerioz, FA | 2 |
Chaijaroenkul, W; Na-Bangchang, K; Wisedpanichkij, R | 1 |
Ariey, F; Beck, HP; Bouth, DM; Chim, P; Chy, S; Coppee, JY; Duong, S; Fandeur, T; Genton, B; Gobert, JG; Khim, N; Kim, S; Le Bras, J; Lim, P; Mercereau-Puijalon, O; Nhem, S; Ringwald, P; Rogers, WO; Sem, R; Wongsrichanalai, C; Yi, P | 1 |
Geng, Y; Klocke, BJ; Kohli, L; Roth, KA | 1 |
Almeras, L; Amalvict, R; Baret, E; Briolant, S; Gil, M; Henry, M; Parquet, V; Pradines, B; Rogier, C; Wurtz, N | 1 |
Lekostaj, JK; Pleeter, P; Roepe, PD | 1 |
Ariey, F; Beck, HP; Decosterd, LA; Duong, S; Genton, B; Hodel, EM; Mercier, T; Olliaro, P; Zanolari, B | 1 |
Puri, SK; Singh, S; Srivastava, K; Srivastava, M; Srivastava, RK | 1 |
Hoffmann, GR; Laterza, AM; Sylvia, KE; Tartaglione, JP | 1 |
Imre, T; Iványi, R; Jicsinszky, L; Mizsei, R; Németh, K; Simonyi, M; Szemán, J; Szente, L; Tárkányi, G; Varga, E; Visy, J | 1 |
Guilleux, M; Jousset, N; Le Bouil, A; Rougé-Maillart, C; Tracqui, A; Turcant, A | 1 |
Bichenkova, E; Cabal, GG; Díaz, C; dos Santos, DJ; Douglas, KT; Guedes, RC; Gut, J; Lavrado, J; Moreira, R; Mota, MM; Paulo, A; Prudêncio, M; Rosenthal, PJ | 1 |
Bisvigou, U; Dinzouna Boutamba, SD; Ekomy, H; Lekana-Douki, JB; Toure-Ndouo, FS; Zang Edou, SE; Zatra, R | 1 |
Bouraima, A; Briand, V; Choudat, I; Cot, M; Cottrell, G; Dechavanne, C; Fayomi, B; Garcia, A; Guerra, J; Le Port, A; Massougbodji, A; Migot-Nabias, F | 1 |
Terlouw, DJ; van Eijk, AM | 1 |
Anderson, TJ; Brumlik, MJ; Curiel, TJ; Kious, MJ; Nkhoma, S; Patterson, TF; Siekierka, JJ; Thompson, GR | 1 |
Amalvict, R; Baret, E; Briolant, S; Charras, S; Feraud, M; Henry, M; Huyghues des Etages, E; Pascual, A; Pradines, B; Rogier, C | 1 |
Chen, B; Coldham, I; Little, SM; Louth, JC; Thompson, MJ | 1 |
Cozens, S; Dow, GS; Gettayacamin, M; Hansukjariya, P; Imerbsin, R; Kenworthy, D; Komcharoen, S; Kyle, D; Milhous, W; Miller, A; Ohrt, C; Sattabongkot, J; Veazey, J | 1 |
Congpuong, K; Sirichaisinthop, J; Treiber, M; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, U | 1 |
Ensom, MH; Wilby, KJ | 1 |
Moreira-Campos, LM; Nogueira, FH; Pianetti, GA; Santos, RL | 1 |
Borer, A; Kafka, M; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Smolyakov, R | 1 |
Bozzo, P; Einarson, A; Irvine, MH | 1 |
Kittikool, D; Sibmooh, N; Srihirun, S; Tangnitipong, S; Thaptimthong, T; Udomsangpetch, R; Unchern, S | 1 |
Berger, F; Bertani, S; Bouchier, C; Ekala, MT; Legrand, E; Mercereau-Puijalon, O; Meynard, JB; Musset, L; Péneau, J; Volney, B; Yrinesi, J | 1 |
Fadden, SJ; Keene, DD; Roughton, S; Tong, JL | 1 |
Al-Farsi, HM; Al-Hashami, ZS; Al-Qahtani, A; Al-Sheikh, AA; Babiker, HA; Bin Dajem, SM | 1 |
Anvikar, AR; Bhatt, RM; Dash, AP; Ghosh, SK; Kumar, A; Mohanty, SS; Pillai, CR; Sharma, B; Sharma, SK; Valecha, N | 1 |
Garner, P; Gelband, H; Graves, PM | 3 |
Abdur, R; Barrette, A; Bouth, DM; Duong, S; Leang, R; Menard, D; Ringwald, P | 1 |
Beeson, JG; Goodman, CD; Langer, C; McFadden, GI; Wilson, DW | 1 |
Dwivedi, H; Pandey, SK; Rizvi, A; Saxena, JK; Tripathi, R | 1 |
Amnuaysirikul, J; Caridha, D; Gao, X; Grogl, M; Hickman, M; Ishida, H; Li, Q; Magill, AJ; O'Neil, MT; Ohrt, C; Ray, P; Weina, PJ; Zhang, P | 1 |
Alcantara, LM; Ayong, LS; Franco, CH; Franzoi, KD; Freitas-Junior, LH; Kim, J; Lee, S; Moraes, CB | 1 |
Cooksey, R; Dahlström, S; Fairhurst, RM; Flegg, JA; Guerin, PJ; Johnson, JD; Le Bras, J; Le Nagard, H; Lim, P; Ménard, D; Mentré, F; Murillo, C; Musset, L; Noedl, H; Nosten, F; Nsobya, SL; Pradines, B; Quashie, NB; Sibley, CH; Sinou, V; Sriprawat, K; Woodrow, CJ | 1 |
Akala, HM; Andagalu, B; Bulimo, W; Cheruiyot, A; Eyase, FL; Ingasia, L; Johnson, JD; Juma, D; Kamau, E; Okudo, C; Omondi, A; Schnabel, D; Walsh, DS; Wanja, E; Waters, NC; Yeda, R | 1 |
Alecrim, MG; Brasil, LW; Chehuan, YF; Costa, JS; Costa, MR; Lacerda, MV; Melo, GC; Monteiro, WM; Nogueira, F; Silveira, H | 1 |
Anderson, TJ; Jamsen, KM; Nair, S; Nosten, F; Price, RN; Simpson, JA; White, NJ; Woodrow, C; Zaloumis, S | 1 |
Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
Abdi, AI; Kiara, SM; Mwai, L; Nzila, A; Ochola-Oyier, LI; Okombo, J; Pole, L; Sutherland, CJ | 1 |
Baresel, PC; Campo, B; Magill, AJ; Ohrt, C; Rochford, R; Sampath, A; Tekwani, BL; Walker, LA | 1 |
du Plessis, LH; Helena, C; Kotzé, AF; van Huysteen, E; Wiesner, L | 1 |
Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
Ahmed, MA; Cox-Singh, J; Fatih, FA; Kocken, CH; Krishna, S; Pasini, EM; Siner, A; Singh, B; Staines, HM; Woon, LC | 1 |
Choi, AR; Kim, JH; Kim, YK; Yoon, S | 1 |
Chaijaroenkul, W; Muhamad, P; Na-Bangchang, K; Phompradit, P; Wisedpanichkij, R | 1 |
Eshleman, AJ; Hinrichs, DJ; Janowsky, A; Johnson, RA; Riscoe, MK; Smilkstein, MJ; Wolfrum, KM; Yang, J; Zabriskie, TM | 1 |
Aguiar, AC; Amaral, NS; De Marco, L; Krettli, AU; Pereira, DB | 1 |
David, K; Møller, CH | 1 |
Cui, L; Gupta, B; Miao, J; Sun, L; Wang, Z; Xu, S; Yang, Z | 1 |
Clark, J; Golenser, J; Guiguemde, WA; Guo, J; Guy, RK; Haynes, RK; Hunt, NH; Marciano, A | 1 |
Albrecht, L; Angerami, RN; Castiñeiras, CM; Costa, FT; Dos-Santos, JC; Garcia, MT; Lacerda, MV; Levy, CE; Lopes, SC; Moretti, ML | 1 |
Arboleda, M; Blair, S; Fernández, D; Garavito, G; Pabón, A; Segura, C | 1 |
Anstey, NM; Barber, BE; Dhanaraj, P; Grigg, MJ; Menon, J; Price, RN; Rajahram, G; von Seidlein, L; William, T; Yeo, TW | 1 |
Baret, E; Bercion, R; Camara, C; Diatta, B; Diémé, Y; Fall, B; Fall, KB; Fall, M; Mbaye, PS; Nakoulima, A; Pascual, A; Pradines, B; Wade, B; Wurtz, N | 1 |
Dahlstrom, S; Ferreira, PE; Franzén, O; Gil, JP; Lum, JK; Nosten, F; Osório, NS; Veiga, MI | 1 |
Bastiaens, GJ; Behet, MC; Bijker, EM; Graumans, W; Hermsen, CC; Obiero, JM; Sauerwein, RW; Schats, R; Scholzen, A; Teelen, K; van de Vegte-Bolmer, M; van Gemert, GJ; van Lieshout, L; Visser, LG | 1 |
Chandra, R; Dieng, Y; Djimdé, AA; Dunne, MW; Kain, KC; Mugyenyi, P; Mulenga, M; Oduro, AR; Ogutu, B; Robbins, J; Sagara, I; Sarkar, S; Sie, A; Tiono, AB; Wasunna, M | 1 |
Bijker, EM; Cockburn, I; Nganou-Makamdop, K; Sauerwein, RW; van Gemert, GJ; Zavala, F | 1 |
Buathong, N; Chanarat, N; Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Heng, TK; Jacob, C; Kong, N; Kuntawunginn, W; Lanteri, CA; Lin, JT; Lon, C; Plowe, C; Prom, S; Saingam, P; Saunders, DL; Se, Y; Sea, D; Sriwichai, S; Sundrakes, S; Takala-Harrison, S; Tangthongchaiwiriya, K; Teja-Isavadharm, P; Tyner, SD; Yingyuen, K; Yom, Y | 1 |
Barnwell, JW; Goldman, I; Juma, E; Kariuki, S; Komino, F; Lucchi, NW; Okoth, SA; Onyona, P; Shi, YP; Udhayakumar, V; Wiegand, RE | 1 |
Cabrera, M; Cui, L | 1 |
Auburn, S; Handayuni, I; Marfurt, J; Noviyanti, R; Pava, Z; Poespoprodjo, JR; Price, RN; To, S; Trianty, L; Wirjanata, G | 1 |
Bannister-Tyrrell, M; Coosemans, M; d'Alessandro, U; Dierickx, S; Durnez, L; Erhart, A; Gerrets, R; Gryseels, C; Hausmann-Muela, S; Hoibak, S; Muela Ribera, J; Peeters Grietens, K; Phoeuk, P; Set, S; Sluydts, V; Suon, S; Tho, S; Trienekens, S; Uk, S | 1 |
Ramharter, M | 1 |
Anstey, NM; Barber, BE; Dhanaraj, P; Grigg, MJ; McCarthy, JS; Menon, J; Pasay, C; Price, RN; Rajahram, GS; von Seidlein, L; Wilkes, CS; William, T; Yeo, TW | 1 |
Anto, F; Ayanful-Torgby, R; Dery, V; Duah, NO; Matrevi, SA; Quashie, NB | 1 |
Akala, HM; Auschwitz, JM; Cheruiyot, AC; Gaona, HW; Hickman, MR; Johnson, JD; Kamau, E; Lee, PJ; Leed, SE; Murthy, T; Okello, CO; Talwar, M; Yeda, RA | 1 |
Bhardwaj, J; Goyal, M; Prakash, K; Puri, SK; Siddiqui, AJ; Soni, A | 1 |
Groger, M; Lötsch, F; Ramharter, M; Rehman, K; Sauerzopf, U; Veletzky, L | 1 |
Anstey, NM; Auburn, S; Barber, BE; Edstein, MD; Grigg, MJ; Menon, J; Price, RN; Rajahram, GS; Wilkes, CS; William, T; Yeo, TW | 1 |
Amalvict, R; Benoit, N; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
Muhamad, P; Na-Bangchang, K; Phompradit, P; Thiengsusuk, A | 1 |
Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
Amalvict, R; Benoit, N; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
Ataide, R; Beeson, JG; Boel, M; Drew, D; Fowkes, FJI; McGready, R; McLean, ARD; Nosten, F; Simpson, JA; Tsuboi, T | 1 |
Agnamey, P; Azas, N; Bentzinger, G; Cohen, A; Dassonville-Klimpt, A; Guillon, J; Hutter, S; Jonet, A; Moreau, S; Mullie, C; Savrimoutou, S; Schneider, J; Sonnet, P; Taudon, N | 1 |
Byaruhanga, O; Ceja, FG; Conrad, MD; Cooper, RA; Katairo, T; Nsobya, SL; Rasmussen, SA; Rosenthal, PJ; Tumwebaze, PK | 1 |
Maayan, N; Pace, C; Saunders, R; Sinclair, D; Tickell-Painter, M | 1 |
Annan, K; Ansah, C; Forkuo, AD; Gyan, B; Mancama, D; Mensah, KB; Theron, A; Wright, CW | 1 |
Choi, L; Garner, P; Gelband, H; Graves, PM | 1 |
Avery, SV; Islahudin, F; Lakhani, DH; Tindall, SM; Ting, KN; Vallières, C | 1 |
Ahmed, AM; Dang, TN; Dat, TV; Egan, TJ; Elhady, MT; Fukuda, M; Giang, HTN; Hirayama, K; Huy, NT; Huynh, LK; Kamel, MG; Kaneko, O; Mizukami, S; Mizuta, S; Mosaddeque, F; Tanaka, Y; Teklemichael, AA; Toan, DV; Vuong, NL | 1 |
Agarwal, P; Anvikar, AR; Pillai, CR; Srivastava, K | 1 |
Fairley, JK; Gutman, JR; Tan, KR; Wang, M | 1 |
Churcher, ZR; Johnson, PE; Slavkovic, S | 1 |
Horii, T; Tougan, T; Toya, Y; Uchihashi, K | 1 |
Banic, DM; Baptista, BO; Bianco-Junior, C; Carvalho, LJM; Cassiano, GC; Daniel-Ribeiro, CT; de Oliveira-Ferreira, J; Lima-Junior, JDC; Machado, RLD; Perce-Da-Silva, DS; Pratt-Riccio, LR; Riccio, EKP; Storti-Melo, LM; Torres, VR; Totino, PRR | 1 |
Brett-Major, D; Fraser, J; Hickey, PW; Mitra, I; Riddle, MS; Tribble, DR | 1 |
Gutman, JR; McKinney, KL; Tan, KR; Wu, HM | 1 |
Bah, S; Dabitao, D; Dama, S; Diakité, M; Diakité, SAS; Doumbia, S; Doumbouya, M; Guindo, MA; Keita, B; Konaté, DS; Sangaré, M; Sanogo, I; Traoré, K | 1 |
Boonyuen, U; Day, NPJ; Dondorp, AM; Imwong, M; Nosten, F; Pimpat, Y; Pukrittayakamee, S; Saralamba, N; Smithuis, F | 1 |
Bensalem, J; Bryksin, V; Fourrier, C; Hattersley, K; Hein, LK; Sargeant, TJ | 1 |
Anywar, DA; Auma, MA; Balikagala, B; Emoto, S; Fukuda, N; Hashimoto, M; Hirai, M; Horii, T; Ikeda, M; Kataoka, M; Katuro, OT; Kimura, E; Mita, T; Mori, T; Obwoya, PS; Odongo-Aginya, EI; Ogwang, M; Opio, W; Palacpac, NMQ; Sakurai-Yatsushiro, M; Sekihara, M; Tachibana, SI; Yamauchi, M; Yatsushiro, S | 1 |
Ahmad, SS; Rahi, M; Ranjan, V; Sharma, A | 1 |
Jongwutiwes, S; Kuamsab, N; Pattanawong, U; Putaporntip, C; Rojrung, R; Seethamchai, S; Weng Cheng, C; Yanmanee, S | 1 |
Barreto-Vieira, DF; Blanco, C; Bou-Habib, DC; Bozza, PT; Chaves, OA; Da Silva, APD; da Silva, CS; da Silva, MAN; Dias, SSG; Ferreira, AC; Fintelman-Rodrigues, N; Mattos, M; Miranda, MD; Owen, A; Paccanaro, A; Pereira-Dutra, F; Rajoli, RKR; Sacramento, CQ; Santos, SS; Soares, VC; Souza, TML; Temerozo, JR; Torres, M | 1 |
Corry, B; Martin, RE; Richards, SN; Shafik, SH | 1 |
Boroujeni, SS; Dehpour, AR; Jafari, RM; Karimi, E; Maleki, A; Mohammadi, P; Sabzevari, O; Shafaroodi, H; Solaimanian, S | 1 |
Iwanaga, S; Kamchonwongpaisan, S; Kubota, R; Nishi, T; Shinzawa, N; Srichairatanakool, S; Syafruddin, D; Uthaipibull, C; Yuda, M | 1 |
Bifani, P; Blackman, MJ; Christensen, P; Chua, ACY; Dhingra, SK; Fidock, DA; Kaneko, O; Kyle, DE; Lee, MCS; Matheson, J; Moon, RW; Racklyeft, A; Remmert, C; Rénia, L; Russell, B; Snounou, G; Suwanarusk, R; Ward, KE | 1 |
Bajpai, S; Banerjee, S; Kushwaha, R; Mandal, A; Mandal, AA; Yadav, AK | 1 |
66 review(s) available for chloroquine and mefloquine
Article | Year |
---|---|
Recent advances in malaria drug discovery.
Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure | 2013 |
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Quinoline hybrids and their antiplasmodial and antimalarial activities.
Topics: Antimalarials; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2017 |
Triazole derivatives and their antiplasmodial and antimalarial activities.
Topics: Animals; Antimalarials; Humans; Parasitic Sensitivity Tests; Plasmodium; Triazoles | 2019 |
New dimensions in the field of antimalarial research against malaria resurgence.
Topics: Animals; Antimalarials; Artemisinins; Drug Resistance; Humans; Malaria; Plasmodium falciparum | 2019 |
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
Trends and controversies in the prophylaxis and treatment of malaria.
Topics: Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine | 1992 |
Plasmodium falciparum malaria in pregnancy: a review.
Topics: Animals; Chloroquine; Critical Care; Female; Humans; Immunocompromised Host; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Infectious | 1992 |
Risks and benefits of prophylactic antimalarial drugs.
Topics: Antimalarials; Chloroquine; Humans; Malaria; Mefloquine; Proguanil; Risk Factors | 1989 |
The problem of drug resistance in malaria.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; India; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
Pharmacokinetics of antimalarial drugs: their therapeutic and toxicological implications.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Half-Life; Humans; Kinetics; Male; Mefloquine; Mice; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine; Sulfalene | 1985 |
[Progress in immunodiagnosis and chemotherapy of protozoan infections].
Topics: Amebiasis; Animals; Antibodies; Babesiosis; Chloroquine; Drug Resistance, Microbial; Giardiasis; Humans; Leishmaniasis; Malaria; Mefloquine; Pneumocystis; Pneumonia, Pneumocystis; Primaquine; Protozoan Infections; Pyrimethamine; Quinine; Quinolines; Serologic Tests; Sulfadoxine; Tetracycline; Toxoplasmosis; Trypanosomiasis | 1983 |
[Urgent need for new antimalarias (author's transl)].
Topics: Antimalarials; Biological Availability; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Immunotherapy; Mefloquine; Piperidines; Pyrimethamine; Quinolines; Sulfadoxine; World Health Organization | 1981 |
The present status of malaria chemotherapy: mefloquine, a novel antimalarial.
Topics: Amodiaquine; Animals; Antimalarials; Aotus trivirgatus; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dogs; Drug Therapy, Combination; Erythrocytes; Female; Humans; Lethal Dose 50; Macaca mulatta; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Primaquine; Proguanil; Protein Conformation; Pyrimethamine; Quinolines; Rats; Stereoisomerism; Swine | 1981 |
Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.
Topics: Chloroquine; Diethylcarbamazine; Drug Resistance; Echinococcosis; Filariasis; Humans; Malaria; Mefloquine; Pharmacokinetics; Phenanthrenes; Pyrimethamine; Quinine; Sulfadoxine; Tropical Medicine | 1994 |
Drug resistance and the P-glycoprotein homologues of Plasmodium falciparum.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Chloroquine; Drug Resistance; Gene Expression; Mefloquine; Membrane Glycoproteins; Phenotype; Protozoan Proteins | 1993 |
[Malaria: the most important emergency in subjects returning from the tropics].
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Emergencies; Humans; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium; Pyrimethamine; Quinidine; Quinine; Sulfadoxine | 1993 |
Prophylaxis against malaria for travellers from the United Kingdom. Malaria Reference Laboratory and the Ross Institute.
Topics: Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Proguanil; Travel | 1993 |
Quinoline antimalarials: mechanisms of action and resistance.
Topics: Animals; Antimalarials; Blood Proteins; Chloroquine; Drug Resistance; Erythrocytes; Hemoglobins; Humans; Mefloquine; Membrane Proteins; Plasmodium; Quinine; Quinolines | 1997 |
[The treatment of malaria].
Topics: Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Pregnancy; Primaquine | 1997 |
Malaria prevention in travelers.
Topics: Animals; Antimalarials; Bedding and Linens; Chloroquine; Doxycycline; Humans; Malaria; Malaria, Falciparum; Mefloquine; Patient Education as Topic; Plasmodium falciparum; Primaquine; Proguanil; Protective Clothing; Teaching Materials; Travel | 1999 |
[Neurological toxicity of antifungal and antiprotozoal drugs].
Topics: Amphotericin B; Antifungal Agents; Antimalarials; Antiprotozoal Agents; Antitrichomonal Agents; Central Nervous System Diseases; Chloroquine; Humans; Mefloquine; Metronidazole; Quinine | 1999 |
Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
Topics: Africa, Eastern; Africa, Western; Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Costs; Humans; Malaria; Mefloquine; Patient Selection; Phenanthrenes; Pyrimethamine; Quinine; Safety; Sulfadoxine; Treatment Outcome | 1999 |
[Malaria in Norway--diagnosis, treatment and prevention].
Topics: Antimalarials; Chloroquine; Humans; Insect Bites and Stings; Malaria; Malaria, Falciparum; Mefloquine; Norway; Practice Guidelines as Topic; Primaquine; Travel | 2000 |
Combination therapy for malaria in Africa: hype or hope?
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Cross-Cultural Comparison; Half-Life; Humans; Insecticide Resistance; Malaria; Mefloquine; Pyrimethamine; Self Medication; Sesquiterpenes; Sulfadoxine; Thailand | 2000 |
Antimalarial chemoprophylaxis in infants and children.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Doxycycline; Humans; Infant; Malaria, Falciparum; Mefloquine; Primaquine | 2001 |
Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
Topics: Animals; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Resistance; Health Planning Guidelines; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Primaquine; Proguanil | 2001 |
[Recommendations for prevention of malaria in patients with epilepsy].
Topics: Adolescent; Adult; Aged; Antimalarials; Chloroquine; Electroencephalography; Epilepsy; Female; Humans; Malaria; Male; Mefloquine; Middle Aged | 2001 |
[Malaria--chemoprophylaxis 2001].
Topics: Africa; Antimalarials; Asia; Atovaquone; Chloroquine; Contraindications; Doxycycline; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Practice Guidelines as Topic; Proguanil; South America; Switzerland; Travel | 2001 |
The Italian army standpoint on malaria chemoprophylaxis.
Topics: Antimalarials; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Humans; Italy; Malaria; Malaria, Falciparum; Mefloquine; Military Personnel; Proguanil; Tropical Climate | 2001 |
The malaria threat.
Topics: Antimalarials; Chloroquine; Doxycycline; Drug Resistance; Health Policy; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Military Personnel; Proguanil | 2001 |
Current drugs for antimalarial chemoprophylaxis: a review of efficacy and safety.
Topics: Antimalarials; Atovaquone; Chloroquine; Doxycycline; Humans; Malaria; Mefloquine; Naphthoquinones; Primaquine; Proguanil | 2001 |
Clinical practice: antimalarial prophylaxis in patients with epilepsy [corrected].
Topics: Antimalarials; Chemoprevention; Chloroquine; Epilepsy; Humans; Malaria; Mefloquine; Risk Factors; Travel; United Kingdom | 2002 |
Safety evaluation of the drugs available to prevent malaria.
Topics: Adult; Animals; Antimalarials; Chemical and Drug Induced Liver Injury; Chloroquine; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Randomized Controlled Trials as Topic; Travel | 2002 |
Military aviators, special operations forces, and causal malaria prophylaxis.
Topics: Aminoquinolines; Antimalarials; Atovaquone; Aviation; Chloroquine; Doxycycline; Drug Combinations; Humans; Malaria; Mefloquine; Military Personnel; Naphthoquinones; Primaquine; Proguanil; United States | 2003 |
Genetic and biochemical aspects of drug resistance in malaria parasites.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Resistance; Drug Resistance, Multiple; Humans; Linkage Disequilibrium; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2004 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
[Malaria: prophylaxis, treatment, stand-by medication. A single mosquito bite suffices].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Atovaquone; Chloroquine; Climate; Doxycycline; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Mefloquine; Naphthoquinones; Pregnancy; Proguanil; Risk Factors; Self Medication; Sesquiterpenes; Time Factors; Travel | 2004 |
Malaria: prevention in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Proguanil; Travel | 2003 |
Malaria: prevention in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Clothing; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Proguanil; Travel | 2004 |
Effectiveness of antimalarial drugs.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Life Cycle Stages; Malaria; Mefloquine; Patient Compliance; Plasmodium; Primaquine; Pyrimethamine; Quinine; Secondary Prevention; Sulfadoxine; Treatment Failure | 2005 |
Malaria: prevention in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Clothing; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Travel | 2004 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
[Malaria chemoprophylaxis].
Topics: Antimalarials; Atovaquone; Chloroquine; Contraindications; Doxycycline; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Mefloquine; Naphthoquinones; Practice Guidelines as Topic; Pregnancy; Proguanil; Risk Assessment; Travel | 2005 |
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
Topics: Animals; Antimalarials; Asia; ATP-Binding Cassette Transporters; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Resistance, Multiple; Folic Acid Antagonists; Genes, Protozoan; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Tetrahydrofolate Dehydrogenase | 2005 |
[Cytochrome P-450 and the response to antimalarial drugs].
Topics: Administration, Oral; Adult; Amodiaquine; Animals; Antimalarials; Biotransformation; Child; Chloroquine; Cytochrome P-450 Enzyme System; Databases as Topic; Disease Models, Animal; Genotype; Humans; Malaria; Malaria, Falciparum; Mefloquine; Mice; Murinae; Mutation; Nutritional Status; Phenotype; Plasmodium berghei; Polymorphism, Genetic; Proguanil; Rats | 2006 |
Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance.
Topics: Africa; Amino Alcohols; Animals; Antimalarials; Artemisinins; Asia, Southeastern; Biological Transport; Calcium-Transporting ATPases; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Gene Amplification; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Models, Biological; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinine; Sesquiterpenes | 2006 |
Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand.
Topics: Age Factors; Animals; Antimalarials; Artemisinins; Asia, Southeastern; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium; Quinine; Sesquiterpenes; Sex Factors; Sulfadoxine | 2007 |
Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Bayes Theorem; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria; Mefloquine; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Clinical inquiries. What is the most effective and safe malaria prophylaxis during pregnancy?
Topics: Abnormalities, Drug-Induced; Antimalarials; Chemoprevention; Chloroquine; Doxycycline; Female; Humans; Malaria; Mefloquine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious | 2008 |
Drugs for preventing malaria in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel | 2009 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Malaria: prevention in travellers.
Topics: Antimalarials; Bedding and Linens; Chloroquine; Humans; Malaria; Mefloquine; Primaquine; Travel | 2010 |
Pharmacokinetics of antimalarials in pregnancy: a systematic review.
Topics: Anti-Bacterial Agents; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 2011 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
WITHDRAWN: Drugs for preventing malaria in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel | 2015 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
Mefloquine for preventing malaria during travel to endemic areas.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel-Related Illness | 2017 |
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
Topics: Adult; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Non-Randomized Controlled Trials as Topic; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine; Time Factors | 2018 |
Mefloquine as a prophylaxis for malaria needs to be revisited.
Topics: Antimalarials; Chloroquine; Humans; Malaria; Mefloquine; Military Personnel | 2021 |
Transition Metal Complexes as Antimalarial Agents: A Review.
Topics: Antimalarials; Chloroquine; Coordination Complexes; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2023 |
47 trial(s) available for chloroquine and mefloquine
Article | Year |
---|---|
Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1992 |
Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine | 1992 |
Clinical trials of mefloquine with tetracycline.
Topics: Acute Disease; Adolescent; Adult; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Pyrimethamine; Sulfadoxine; Tetracycline | 1992 |
Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Nigeria; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Animals; Antimalarials; Cambodia; Chloroquine; Confidence Intervals; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Survival Analysis; Thailand | 1991 |
Sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and mefloquine in Ibadan, Nigeria.
Topics: Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; In Vitro Techniques; Infant; Malaria; Male; Mefloquine; Nigeria; Plasmodium falciparum; Quinolines | 1988 |
Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Topics: Animals; Antimalarials; Child; Chloroquine; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Male; Mefloquine; Nigeria; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1988 |
Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
Topics: Adolescent; Adult; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Topics: Adolescent; Adult; Animals; Antimalarials; Aspartate Aminotransferases; Blood Cell Count; Child; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Humans; Malaria; Male; Mefloquine; Middle Aged; Nigeria; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1988 |
Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
Topics: Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Evaluation; Drug Resistance; Female; Humans; Malaria; Male; Mefloquine; Nigeria; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1988 |
Parasitologic and clinical efficacy of 25 and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children.
Topics: Animals; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Rwanda | 1988 |
A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand.
Topics: Child; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Quinolines; Thailand | 1987 |
A clinical trial of mefloquine in the treatment of Plasmodium vivax malaria.
Topics: Adult; Chloroquine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium vivax; Primaquine; Quinolines; Random Allocation | 1985 |
The problem of drug resistance in malaria.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; India; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
A comparative clinical study of mefloquine and chloroquine in the treatment of vivax malaria.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium vivax; Quinolines | 1985 |
A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Humans; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Random Allocation | 1983 |
A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines | 1983 |
The present status of malaria chemotherapy: mefloquine, a novel antimalarial.
Topics: Amodiaquine; Animals; Antimalarials; Aotus trivirgatus; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dogs; Drug Therapy, Combination; Erythrocytes; Female; Humans; Lethal Dose 50; Macaca mulatta; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Primaquine; Proguanil; Protein Conformation; Pyrimethamine; Quinolines; Rats; Stereoisomerism; Swine | 1981 |
Malaria prophylaxis. Toxicity of mefloquine is similar to that of other chemoprophylaxis.
Topics: Chloroquine; Double-Blind Method; Humans; Malaria; Mefloquine; Proguanil | 1995 |
Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil.
Topics: Adolescent; Child; Chloroquine; Doxycycline; Drug Administration Schedule; Humans; Kenya; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil | 1995 |
Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.
Topics: Adult; Animals; Antibodies, Protozoan; Blood; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand | 1993 |
Long-term malaria prophylaxis with weekly mefloquine.
Topics: Africa, Western; Chloroquine; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Humans; Long-Term Care; Malaria, Falciparum; Mefloquine; Proguanil | 1993 |
Mefloquine or doxycycline prophylaxis in US troops in Somalia.
Topics: Animals; Chloroquine; Doxycycline; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Military Personnel; Patient Compliance; Plasmodium falciparum; Premedication; Somalia; United States | 1993 |
Tolerability of prophylactic Lariam regimens.
Topics: Adult; Anorexia; Chloroquine; Depression; Dizziness; Double-Blind Method; Dreams; Drug Tolerance; Eye; Humans; Irritable Mood; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Nausea; Psychomotor Performance; Sleep; Sleep Initiation and Maintenance Disorders; Travel; United States | 1993 |
Recent military experience with malaria chemoprophylaxis.
Topics: Antimalarials; Australia; Chloroquine; Dapsone; Doxycycline; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Personnel; Primaquine; Pyrimethamine | 1993 |
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drugs, Chinese Herbal; Erythrocytes; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Recurrence; Sesquiterpenes; Tanzania | 1995 |
Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Humans; Malaria, Falciparum; Malawi; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prospective Studies; Risk Factors; Rural Population; Seasons | 1996 |
Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Fetal Blood; Humans; Malaria, Falciparum; Malawi; Mefloquine; Obstetric Labor Complications; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Rural Population; Treatment Outcome | 1996 |
Objectives and methodology in a study of malaria treatment and prevention in pregnancy in rural Malawi: The Mangochi Malaria Research Project.
Topics: Antimalarials; Chloroquine; Female; Fetal Death; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Malaria, Falciparum; Malawi; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Research Design; Rural Population; Surveys and Questionnaires; Treatment Outcome | 1996 |
[Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Female; France; Humans; Kenya; Malaria; Male; Mefloquine; Patient Compliance; Proguanil; Senegal; Surveys and Questionnaires; Travel | 1997 |
Response of falciparum malaria to different antimalarials in Myanmar.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine | 1999 |
In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance.
Topics: Adult; Animals; Antimalarials; Artemisinins; Chloroquine; Cross Reactions; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Models, Biological; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Recurrence; Sesquiterpenes | 2001 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Malaria in a cohort of Javanese migrants to Indonesian Papua.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Incidence; Indonesia; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Papua New Guinea; Parasitemia; Prevalence; Transients and Migrants | 2003 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2004 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
Topics: Adult; Antimalarials; Child; Chloroquine; Drug Resistance; Humans; Indonesia; Japan; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Treatment Outcome | 2006 |
Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin.
Topics: Administration, Oral; Animals; Antigens, Protozoan; Antimalarials; Benin; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2007 |
Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.
Topics: Adult; Antimalarials; Benin; Chloroquine; Drug Combinations; Female; Health Policy; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Maternal Age; Mefloquine; Multivariate Analysis; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2011 |
A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Female; Humans; Malaria; Malaysia; Male; Mefloquine; Plasmodium knowlesi; Research Design; Severity of Illness Index | 2014 |
Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial.
Topics: Adolescent; Adult; Antibodies; Antimalarials; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chloroquine; DNA, Protozoan; Double-Blind Method; Erythrocytes; Granzymes; Healthy Volunteers; Humans; Immunity, Cellular; Lysosomal-Associated Membrane Protein 1; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Sporozoites; Young Adult | 2014 |
Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Azithromycin; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome; Uganda; Young Adult; Zambia | 2014 |
Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria; Malaysia; Male; Mefloquine; Middle Aged; Plasmodium knowlesi; Young Adult | 2016 |
Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Infant; Malaria, Vivax; Male; Mefloquine; Middle Aged; Plasmodium vivax; Treatment Outcome; Young Adult | 2016 |
Changing Antimalarial Drug Sensitivities in Uganda.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Child; Child, Preschool; Chloroquine; Drug Resistance; Ethanolamines; Female; Fluorenes; Gene Expression; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinolines; Uganda; Young Adult | 2017 |
457 other study(ies) available for chloroquine and mefloquine
Article | Year |
---|---|
From a cytotoxic agent to the discovery of a novel antimalarial agent.
Topics: Antimalarials; Caco-2 Cells; Drug Discovery; Drug Resistance; Humans; Inhibitory Concentration 50; Morpholines; Piperidones; Plasmodium falciparum | 2013 |
Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres.
Topics: Absorption; Adamantane; Animals; Antimalarials; Dioxolanes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Male; Mice; Peroxides; Plasmodium berghei; Plasmodium falciparum; Spiro Compounds; Structure-Activity Relationship; Tetraoxanes | 2013 |
3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Resistance; Hep G2 Cells; Humans; Liver; Malaria; Malaria, Falciparum; Mice; Piperidones; Plasmodium berghei; Plasmodium falciparum | 2013 |
Design, synthesis and biological evaluation of 3-[4-(7-chloro-quinolin-4-yl)-piperazin-1-yl]-propionic acid hydrazones as antiprotozoal agents.
Topics: Antiprotozoal Agents; Drug Design; Entamoeba histolytica; Entamoebiasis; Humans; Hydrazones; Malaria, Falciparum; Plasmodium falciparum; Propionates | 2014 |
Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
Topics: Animals; Antimalarials; Biological Availability; Drug Design; Drug Resistance; Drug Stability; Gene Library; Half-Life; High-Throughput Screening Assays; Imidazoles; Malaria; Malaria, Falciparum; Mice; Mice, SCID; Parasitic Sensitivity Tests; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Protein Kinase Inhibitors; Protein Kinases; Pyridazines; Rats; Structure-Activity Relationship | 2014 |
Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria.
Topics: Aminoquinolines; Animals; Antimalarials; Botulinum Toxins, Type A; Chick Embryo; Chloroquine; Drug Resistance; Hep G2 Cells; Humans; Metalloproteases; Molecular Docking Simulation; Plasmodium falciparum; Protease Inhibitors; Structure-Activity Relationship | 2014 |
Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
Topics: Animals; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Female; Hep G2 Cells; Humans; Leishmania; Macrophages; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2014 |
Sphingolipid analogues inhibit development of malaria parasites.
Topics: | 2012 |
Identification and optimization of an aminoalcohol-carbazole series with antimalarial properties.
Topics: | 2013 |
Blood schizontocidal and gametocytocidal activity of 3-hydroxy-N'-arylidenepropanehydrazonamides: a new class of antiplasmodial compounds.
Topics: Animals; Antimalarials; Chloroquine; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship | 2014 |
Synthesis of novel triazole-linked mefloquine derivatives: biological evaluation against Plasmodium falciparum.
Topics: Antimalarials; Humans; Malaria; Mefloquine; Molecular Structure; Plasmodium falciparum; Structure-Activity Relationship; Triazoles | 2014 |
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
Topics: Antimalarials; Humans; Malaria; Models, Molecular; Molecular Structure; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Quercetin; Stereoisomerism | 2015 |
Prodrugs of reverse fosmidomycin analogues.
Topics: Animals; Antimalarials; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Fosfomycin; HeLa Cells; Humans; Malaria; Mice; Mice, SCID; Molecular Structure; Plasmodium berghei; Plasmodium falciparum; Prodrugs; Structure-Activity Relationship | 2015 |
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Azabicyclo Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship; Tissue Distribution; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2015 |
Synthesis and antimalarial evaluation of prodrugs of novel fosmidomycin analogues.
Topics: Antimalarials; Drug Evaluation, Preclinical; Fosfomycin; Humans; Prodrugs | 2015 |
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
Topics: Animals; Antimalarials; Ether-A-Go-Go Potassium Channels; Humans; Liver; Malaria; Malaria, Falciparum; Mice; Plasmodium berghei; Plasmodium falciparum; Pyrazoles; Pyridines; Rats; Structure-Activity Relationship | 2015 |
Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?
Topics: Aminoquinolines; Animals; Antimalarials; Drug Evaluation, Preclinical; Ether-A-Go-Go Potassium Channels; Hemin; Hepatocytes; Humans; In Vitro Techniques; Liver; Mice; Microsomes, Liver; Parasite Load; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Tetraoxanes | 2016 |
Conjugation of N-acylhydrazone and 1,2,4-oxadiazole leads to the identification of active antimalarial agents.
Topics: Animals; Antimalarials; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Hydrazones; Malaria; Mice; Molecular Structure; Oxadiazoles; Plasmodium falciparum; Structure-Activity Relationship | 2016 |
Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors.
Topics: Animals; Antimalarials; Cell Line, Tumor; Chlorocebus aethiops; Drug Design; Humans; Molecular Docking Simulation; Plasmodium falciparum; Protein Conformation; Protein Kinase Inhibitors; Protein Kinases; Protozoan Proteins; Pyrimidines; Vero Cells | 2016 |
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.
Topics: Animals; Antimalarials; Disease Models, Animal; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Mice; Mice, SCID; Microsomes, Liver; Molecular Structure; Parasitic Diseases, Animal; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Pyrazines; Solubility; Structure-Activity Relationship; Water | 2016 |
2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Drug Design; Mefloquine; Quinolines; Structure-Activity Relationship; Vero Cells; Virus Replication; Zika Virus | 2017 |
3-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally.
Topics: Amides; Animals; Antimalarials; Hep G2 Cells; Humans; Hydrazones; Malaria; Mice; Phenanthrenes; Plasmodium berghei; Stereoisomerism; Structure-Activity Relationship | 2017 |
Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P
Topics: Amino Acids; Antimalarials; Aspartic Acid Endopeptidases; Dose-Response Relationship, Drug; Molecular Structure; Parasitic Sensitivity Tests; Peptidomimetics; Plasmodium falciparum; Protease Inhibitors; Structure-Activity Relationship | 2018 |
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Plasmodium; Species Specificity; Structure-Activity Relationship; Triazines | 2019 |
New hybrid trifluoromethylquinolines as antiplasmodium agents.
Topics: Animals; Antimalarials; Cell Line; Drug Discovery; Erythrocytes; Halogenation; Haplorhini; Humans; Malaria; Methylation; Mice; Plasmodium berghei; Plasmodium falciparum; Quinolines | 2019 |
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Animals; Antimalarials; Disease Models, Animal; Drug Discovery; Hep G2 Cells; Humans; Malaria; Mice; Plasmodium; Species Specificity; Structure-Activity Relationship | 2019 |
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in
Topics: Amides; Antimalarials; Drug Resistance, Microbial; Hemeproteins; Hemoglobins; Hep G2 Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship; Tetrazoles | 2021 |
Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
Topics: Antimalarials; Artemisinins; Atovaquone; Dose-Response Relationship, Drug; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Triclosan | 2021 |
Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
Topics: Antimalarials; Benzimidazoles; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Humans; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2021 |
Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in vitro antimalarial activity.
Topics: Amino Alcohols; Animals; Antimalarials; Cell Line; Cricetulus; Dose-Response Relationship, Drug; Drug Design; Ether-A-Go-Go Potassium Channels; Female; Humans; Malaria; Mice; Mice, Inbred BALB C; Microsomes, Liver; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2022 |
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
[Current health information for Spanish travellers to tropical areas].
Topics: Centers for Disease Control and Prevention, U.S.; Chloroquine; Health Education; Humans; Information Services; Malaria; Mefloquine; Proguanil; Spain; Travel; United States; World Health Organization | 1992 |
[Treatment of malaria in children in France].
Topics: Antimalarials; Child; Chloroquine; France; Humans; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Phenanthrenes; Quinine | 1992 |
Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Chromosome Deletion; Chromosome Mapping; Dose-Response Relationship, Drug; Drug Resistance; Gene Amplification; Mefloquine; Membrane Glycoproteins; Plasmodium falciparum; Restriction Mapping; Verapamil | 1992 |
Inhibition of the Salmonella typhi oral vaccine strain, Ty21a, by mefloquine and chloroquine.
Topics: Chloroquine; Humans; Mefloquine; Salmonella typhi; Typhoid-Paratyphoid Vaccines; Vaccines, Attenuated | 1992 |
Chloroquine-resistant Plasmodium vivax: it may be a common problem.
Topics: Animals; Chloroquine; Drug Resistance; Female; Humans; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Primaquine | 1992 |
Effects of antimalarial chemoprophylactic agents on the viability of the Ty21a typhoid vaccine strain.
Topics: Chloroquine; Mefloquine; Microbial Sensitivity Tests; Salmonella typhi; Typhoid-Paratyphoid Vaccines | 1992 |
Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon.
Topics: Administration, Oral; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine | 1992 |
Use of antiprotozoan and anthelmintic drugs during pregnancy: side-effects and contra-indications.
Topics: Abnormalities, Drug-Induced; Anthelmintics; Antimalarials; Antiprotozoal Agents; Chloroquine; Contraindications; Female; Helminthiasis; Humans; Infant, Newborn; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Protozoan Infections | 1992 |
Mefloquine-halofantrine cross-resistance in Plasmodium falciparum induced by intermittent mefloquine pressure.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine | 1992 |
Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal.
Topics: Adolescent; Adult; Aminoquinolines; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Humans; In Vitro Techniques; Infant; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum | 1992 |
Type RI resistance to halofantrine in West Africa.
Topics: Animals; Antimalarials; Biological Availability; Chloroquine; Cote d'Ivoire; Drug Resistance; Follow-Up Studies; France; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Phenanthrenes; Plasmodium falciparum; Quinine; Recurrence; Travel | 1991 |
Effect on sodium sulphate on the adsorption of chloroquine and mefloquine to activated charcoal.
Topics: Adsorption; Charcoal; Chloroquine; Humans; Mefloquine; Sulfates | 1991 |
[Malaria in the republic of São Tomé and Principe. Epidemiologic evaluation and chemoresistance of P. falciparum].
Topics: Age Factors; Animals; Antimalarials; Atlantic Islands; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Seasons; Sex Factors; Splenomegaly | 1991 |
Severe falciparum malaria (21 cases).
Topics: Adolescent; Adult; Child, Preschool; Chloroquine; Exchange Transfusion, Whole Blood; Female; Humans; Infusions, Intravenous; Intensive Care Units; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinine; Respiration, Artificial; Retrospective Studies | 1991 |
Malaria prophylaxis.
Topics: Chloroquine; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Travel; Zimbabwe | 1991 |
Drug use and design in the nineties.
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Artemisinins; Calcium Channel Blockers; Chloroquine; Humans; Malaria; Mefloquine; Naphthoquinones; Phenanthrenes; Primaquine; Quinine; Sesquiterpenes; Sulfadoxine | 1991 |
[Prophylaxis of malaria].
Topics: Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Mefloquine | 1991 |
[Prevention and treatment of malaria in expatriates living in Black Africa. Influence of chemoresistance. Investigations conducted in Brazzaville (Congo)].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance, Microbial; Europe; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Indonesia; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Infection of Aotus vociferans monkeys with different strains of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Anopheles; Cebidae; Chloroquine; Malaria; Mefloquine; Plasmodium falciparum; Time Factors | 1991 |
Standard and reduced doses of mefloquine for treatment of Plasmodium falciparum in Tanzania: whole blood concentrations in relation to adverse reactions, in vivo response, and in vitro susceptibility.
Topics: Adolescent; Animals; Child; Chloroquine; Drug Administration Schedule; Humans; Malaria; Mefloquine; Plasmodium falciparum; Tanzania | 1991 |
[Malaria of importation in the child: epidemiological, clinical and therapeutic analysis. Apropos of 70 cases observed in a pediatric hospital in Paris].
Topics: Africa; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Malaria; Malaria, Falciparum; Mefloquine | 1991 |
Imported Plasmodium falciparum malaria in American travelers to Africa. Implications for prevention strategies.
Topics: Africa, Eastern; Africa, Western; Animals; Chloroquine; Drug Resistance; Malaria; Mefloquine; Plasmodium falciparum; Population Surveillance; Travel; United States | 1991 |
Chloroquine-resistant Plasmodium falciparum with reduced sensitivity in vitro to mefloquine and quinine in Zaria, northern Nigeria.
Topics: Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Malaria; Mefloquine; Nigeria; Plasmodium falciparum; Quinine | 1991 |
The chemical basis for the ferriprotoporphyrin IX-chloroquine complex induced lipid peroxidation.
Topics: Animals; Antimalarials; Apoproteins; Benzoates; Benzoic Acid; Catalase; Chloroquine; Hemin; Hydrogen-Ion Concentration; Iron; Kinetics; Lipid Peroxidation; Liposomes; Mefloquine; Oxygen; Primaquine; Quinine; Rats; Spectrum Analysis; Superoxide Dismutase; Transferrin | 1991 |
Widespread in vitro resistance to chloroquine of Plasmodium falciparum in the Congo, 1987.
Topics: Adolescent; Animals; Child; Child, Preschool; Chloroquine; Congo; Drug Resistance; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Quinine; Regression Analysis | 1991 |
In vitro and clinical correlates of mefloquine resistance of Plasmodium falciparum in eastern Thailand.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Butylated Hydroxytoluene; Chloroquine; Drug Resistance; Drugs, Chinese Herbal; Mefloquine; Molecular Structure; Phenanthrenes; Plasmodium falciparum; Pyridines; Pyrimethamine; Quinine; Sesquiterpenes; Thailand | 1991 |
[Imported malaria in Bordeaux in 1989. Epidemiologic, clinical and therapeutic study of 71 cases].
Topics: Animals; Antimalarials; Chloroquine; Female; France; Humans; Malaria; Male; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Travel | 1990 |
An in-vitro profile of the action of four antimalarials on indigenous cases of Plasmodium falciparum malaria in Karnataka.
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance, Microbial; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine | 1990 |
[A case of Plasmodium falciparum malaria contracted in Guinea-Bissau during chemoprophylaxis with chloroquine].
Topics: Animals; Chloroquine; Drug Resistance; Female; Humans; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Quinine | 1990 |
Recommendations for the prevention of malaria among travelers.
Topics: Adult; Animals; Antimalarials; Breast Feeding; Centers for Disease Control and Prevention, U.S.; Child; Chloroquine; Doxycycline; Drug Resistance; Female; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Primaquine; Proguanil; Risk Factors; Travel; United States | 1990 |
Malaria prophylaxis in travellers to tropical Africa.
Topics: Africa; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine; Travel | 1990 |
[Cross resistance to mefloquine and halofantrine in a case of P. falciparum malaria contracted in Sierra Leone].
Topics: Adult; Animals; Antimalarials; Chloroquine; Cross Reactions; Drug Resistance; Humans; Malaria; Male; Mefloquine; Phenanthrenes; Plasmodium falciparum | 1990 |
[Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1990 |
Micro in vitro assessment of Plasmodium falciparum sensitivity to chloroquine and mefloquine in Gujarat.
Topics: Animals; Chloroquine; Drug Resistance; Humans; India; Mefloquine; Plasmodium falciparum | 1990 |
Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis.
Topics: Animals; Chloroquine; Drug Resistance, Microbial; Leishmania mexicana; Mefloquine; Pentamidine; Plasmodium falciparum; Structure-Activity Relationship | 1990 |
[Plasmodium falciparum drug resistance in the Congo. Evaluation of surveys carried out from 1985 to 1989].
Topics: Adolescent; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1990 |
[Development of chemoresistance of Plasmodium falciparum to chloroquine and mefloquine in Benin between 1980 and 1989].
Topics: Animals; Benin; Child; Chloroquine; Drug Resistance; Humans; Mefloquine; Plasmodium falciparum | 1990 |
The Peruvian III strain of Plasmodium brasilianum in Saimiri sciureus boliviensis monkeys.
Topics: Animals; Anopheles; Chloroquine; Malaria; Mefloquine; Monkey Diseases; Recurrence; Saimiri | 1990 |
Potentiation of chloroquine activity against Plasmodium falciparum by the peroxidase-hydrogen peroxide system.
Topics: Animals; Cells, Cultured; Chloroquine; Drug Synergism; Hydrogen Peroxide; Hypoxanthine; Hypoxanthines; Mefloquine; Peroxidases; Plasmodium falciparum; Quinine | 1990 |
A nuclear magnetic resonance study of the interactions of the antimalarials chloroquine, quinacrine, quinine and mefloquine with lipids extracted from normal human erythrocytes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antimalarials; Chloroquine; Deuterium; Erythrocytes; Humans; Magnetic Resonance Spectroscopy; Mefloquine; Membrane Lipids; Phosphatidylethanolamines; Phosphorus Isotopes; Quinacrine; Quinine | 1990 |
Effects of mefloquine on the release of marker enzymes from the rat liver crude lysosomal fraction.
Topics: Acid Phosphatase; Animals; Biomarkers; Chloroquine; Glucuronidase; In Vitro Techniques; Liver; Lysosomes; Mefloquine; Proteins; Rats | 1990 |
Effects of chloroquine, mefloquine and quinine on natural killer cell activity in vitro. An analysis of the inhibitory mechanism.
Topics: Cell Adhesion; Chloroquine; Cytotoxicity, Immunologic; Humans; Immunity, Cellular; Immunity, Innate; In Vitro Techniques; Interferons; Interleukin-2; Killer Cells, Natural; Mefloquine; Quinine; Quinolines | 1986 |
[The role of mefloquine in the prevention of malaria].
Topics: Africa; Chloroquine; Drug Resistance, Microbial; Drug Tolerance; France; Humans; Malaria; Mefloquine | 1989 |
A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinolines; Thailand | 1989 |
The response of Plasmodium falciparum to chloroquine and mefloquine in Bandar-Abbas and Minab areas, Hormozgan Province, southern Iran.
Topics: Adolescent; Adult; Animals; Child; Chloroquine; Drug Resistance; Humans; Iran; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines | 1989 |
Ultrastructure of Plasmodium falciparum "in vitro". II. Morphological patterns of different quinolines effects.
Topics: Animals; Antimalarials; Chloroquine; Indoles; Mefloquine; Microscopy, Electron; Molecular Structure; Plasmodium falciparum; Quinolines | 1989 |
[Surveillance of Plasmodium falciparum drug sensitivity in Yaounde and its surroundings (Cameroon). In vivo and in vitro study].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chloroquine; Humans; In Vitro Techniques; Infant; Malaria; Mefloquine; Microbial Sensitivity Tests; Middle Aged; Plasmodium falciparum; Quinine; Quinolines; Rural Population | 1989 |
Antimalarial drug susceptibility of Plasmodium falciparum isolates from forest fringe dwelling aborigines (Orang Asli) of Peninsular Malaysia.
Topics: Animals; Antimalarials; Child; Chloroquine; Drug Resistance; Humans; Malaria; Malaysia; Mefloquine; Plasmodium falciparum; Quinolines | 1989 |
Drug resistant P. falciparum in Madras (Tamil Nadu) and district Jabalpur (Madhya Pradesh).
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; India; Malaria; Male; Mefloquine; Plasmodium falciparum | 1989 |
[A handy medium for in vitro assessment of sensitivity of Plasmodium falciparum to chloroquine and mefloquine in the field].
Topics: Animals; Chloroquine; Culture Media; Drug Resistance; Mefloquine; Plasmodium falciparum | 1989 |
[Sensitivity of Plasmodium falciparum to different antimalarials. A study in 1988 in a village in the Hauts-Plateaux of Madagascar].
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Madagascar; Mefloquine; Plasmodium falciparum; Quinine | 1989 |
Status of the response of Plasmodium falciparum to chloroquine and mefloquine in Iran.
Topics: Afghanistan; Animals; Chloroquine; Drug Resistance; Female; Humans; India; Iran; Malaria; Male; Mefloquine; Pakistan; Plasmodium falciparum | 1989 |
A nuclear magnetic resonance study of the interactions of the antimalarials chloroquine, quinacrine, quinine and mefloquine with dipalmitoylphosphatidylcholine bilayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antimalarials; Chloroquine; Lipid Bilayers; Magnetic Resonance Spectroscopy; Mefloquine; Quinacrine; Quinine; Quinolines; Temperature | 1989 |
Is plasmodium falciparum resistance to chloroquine reversible in absence of drug pressure?
Topics: Adolescent; Child; Child, Preschool; Chloroquine; Drug Interactions; Drug Resistance, Microbial; Humans; Malaria; Mefloquine; Plasmodium falciparum; Quinolines; Vietnam | 1985 |
In-vitro chloroquine and mefloquine-resistant Plasmodium falciparum in Nigeria.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Mefloquine; Nigeria; Plasmodium falciparum; Quinolines | 1987 |
High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Chloroquine; Female; Follow-Up Studies; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Quinidine; Quinine; Quinolines; Recurrence; Thailand | 1987 |
In vitro sensitivity of Plasmodium falciparum isolates from Burma to chloroquine quinine and mefloquine.
Topics: Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; Mefloquine; Myanmar; Plasmodium falciparum; Quinine; Quinolines | 1985 |
Plasmodium falciparum: inhibition of dolichol kinase by mefloquine.
Topics: Animals; Artemisinins; Cations, Divalent; Chloroquine; Cytidine Triphosphate; Detergents; Dolichols; Egtazic Acid; Erythrocytes; Hydrogen-Ion Concentration; Kinetics; Mefloquine; Microsomes; Nucleotides; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Plasmodium falciparum; Quinolines; Sesquiterpenes; Trifluoperazine | 1986 |
[In vitro activity of various antimalarials (chloroquine, amodiaquine, quinine and mefloquine) against 32 isolates of Plasmodium falciparum in French Guiana].
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance; French Guiana; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1988 |
Response of Kampuchean strains of Plasmodium falciparum to antimalarials: in-vivo assessment of quinine and quinine plus tetracycline; multiple drug resistance in vitro.
Topics: Adolescent; Adult; Animals; Cambodia; Chloroquine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; In Vitro Techniques; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinine; Quinolines; Tetracycline | 1988 |
Patterns of in vitro resistance to chloroquine, quinine, and mefloquine of Plasmodium falciparum in Cameroon, 1985-1986.
Topics: Adolescent; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Mefloquine; Plasmodium falciparum; Quinine; Quinolines; Time Factors | 1988 |
[The chloroquine resistance of Plasmodium falciparum in Vanuatu (1980-1984): appearance, evolution, distribution].
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Chloroquine; Culture Media; Drug Resistance; Humans; Infant; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Vanuatu | 1988 |
Response of Plasmodium falciparum to antimalarial drugs in vitro at Wad Medani, Sudan.
Topics: Animals; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinolines; Sudan | 1988 |
Serial studies on the evolution of drug resistance in malaria in an area of east Africa: findings from 1979 up to 1986.
Topics: Age Factors; Amodiaquine; Animals; Antibodies, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinidine; Quinine; Quinolines; Sulfadoxine; Tanzania | 1988 |
Susceptibility of Plasmodium falciparum to chloroquine and mefloquine in Somalia.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Quinolines; Somalia | 1988 |
Antagonism of chloroquine with other antimalarials.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1988 |
In vitro response of Plasmodium falciparum to chloroquine and mefloquine in southeast Madagascar.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; In Vitro Techniques; Madagascar; Mefloquine; Plasmodium falciparum; Quinolines | 1988 |
In-vivo susceptibility of Plasmodium falciparum to cholorquine in pregnant and non-pregnant women and in-vitro response of P. falciparum to chloroquine and mefloquine in Madang Province, Papua New Guinea.
Topics: Animals; Antimalarials; Chloroquine; Female; Humans; In Vitro Techniques; Malaria; Mefloquine; Papua New Guinea; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Quinolines | 1988 |
Chloroquine-resistant Plasmodium falciparum in Mali revealed by congenital malaria.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Resistance; Female; Humans; Infant, Newborn; Malaria; Mali; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1988 |
Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Erythromycin; Female; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1988 |
[Characterization of 15 strains of Plasmodium falciparum in 8 areas of the Brazilian Amazon region].
Topics: Animals; Antigens, Protozoan; Antimalarials; Brazil; Chloroquine; Mefloquine; Plasmodium falciparum | 1986 |
Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.
Topics: Amodiaquine; Antimalarials; Blood Glucose; Chloroquine; Humans; Hypoglycemia; Insulin; Mefloquine; Phenanthrenes; Quinidine; Quinolines; Thailand | 1986 |
Inhibition of human placental aromatase by mefloquine.
Topics: Antimalarials; Aromatase Inhibitors; Chloroquine; Female; Humans; Mefloquine; Microsomes; Placenta; Pregnancy; Quinolines; Structure-Activity Relationship | 1988 |
Evidence for electrogenic accumulation of mefloquine by malarial parasites.
Topics: Animals; Antimalarials; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chloroquine; Dose-Response Relationship, Drug; Electrochemistry; Erythrocyte Membrane; Hydrogen-Ion Concentration; Ionophores; Mefloquine; Methylamines; Mice; Plasmodium; Quinolines; Temperature; Valinomycin | 1988 |
Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.
Topics: Amodiaquine; Antimalarials; Cell Survival; Cell-Free System; Chemotaxis, Leukocyte; Chloroquine; Humans; Mefloquine; Neutrophils; Oxidation-Reduction; Phagocytosis; Quinolines | 1988 |
Simultaneous determination of mefloquine and chloroquine in biological fluids using high-performance liquid chromatography.
Topics: Antimalarials; Chloroquine; Chromatography, High Pressure Liquid; Humans; Mefloquine; Methaqualone; Quinolines | 1988 |
Evaluation of an in vitro assay system for drug susceptibility of field isolates of Plasmodium falciparum from southern Thailand.
Topics: Amodiaquine; Animals; Antimalarials; Butylated Hydroxytoluene; Chloroquine; Humans; Mefloquine; Parasitology; Phenanthrenes; Plasmodium falciparum; Pyridines; Pyrimethamine; Quinine; Quinolines; Thailand; Triazines | 1988 |
In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Chemical Phenomena; Chemistry; Chloroquine; Drug Resistance; Humans; Mefloquine; Naphthyridines; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Thailand | 1988 |
Effects of quinoline-containing antimalarials on the erythrocyte membrane and their significance to drug action on Plasmodium falciparum.
Topics: Animals; Antimalarials; Chloroquine; Erythrocyte Membrane; Hemolysis; Humans; Hydrogen-Ion Concentration; Mefloquine; Phospholipids; Plasmodium falciparum; Potassium; Proteins; Quinine; Quinolines | 1988 |
Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
Topics: Animals; Chloroquine; Drug Combinations; Drug Resistance; Gabon; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1988 |
In vitro susceptibility of Plasmodium falciparum to amodiaquine, mefloquine, quinine and chloroquine in Liberia, West Africa.
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance; Liberia; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1986 |
A study of the sensitivity of Plasmodium falciparum to chloroquine and mefloquine using the in vitro microtechnique in Peninsular Malaysia.
Topics: Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria; Malaysia; Mefloquine; Parasitology; Plasmodium falciparum; Quinolines | 1987 |
Comparison of washed and unwashed specimens in the Plasmodium falciparum in vitro microculture drug assay.
Topics: Animals; Chloroquine; Drug Resistance; Humans; Mefloquine; Parasitology; Plasmodium falciparum; Quinolines; Specimen Handling | 1987 |
In vitro drug response of Plasmodium falciparum in the Philippines: increased resistance to amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Philippines; Plasmodium falciparum; Quinine; Quinolines | 1987 |
Flunarizine and verapamil inhibit chloroquine-resistant Plasmodium falciparum growth in vitro.
Topics: Animals; Antimalarials; Chloroquine; Chlorpromazine; Drug Resistance; Flunarizine; Mefloquine; Plasmodium falciparum; Quinine; Quinolines; Regression Analysis; Verapamil | 1987 |
[2 cases of multiresistant Plasmodium falciparum malaria contracted in Douala with atypical clinical presentation].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cameroon; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1987 |
[Sensitivity of Plasmodium falciparum to quinolines and therapeutic strategies: comparison of the situation in Africa and Madagascar between 1983 and 1986].
Topics: Amodiaquine; Angola; Animals; Antimalarials; Burkina Faso; Cameroon; Chloroquine; Drug Resistance; Humans; Madagascar; Malaria; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1987 |
Amodiaquine fails to cure chloroquine resistant Plasmodium falciparum in the Punjab.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Pakistan; Plasmodium falciparum; Quinolines | 1987 |
[Susceptibility of Plasmodium falciparum to chloroquine, piperaquine, amodiaquine, mefloquine and quinine with in vitro microtechnique in Hainan Island].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Synergism; Mefloquine; Plasmodium falciparum; Quinolines | 1987 |
Filaricidal effect of mefloquine on adults and microfilariae of Brugia patei and Brugia malayi.
Topics: Animals; Anthelmintics; Blood Proteins; Brugia; Chloroquine; Filaricides; Mefloquine; Microfilariae; Quinolines | 1987 |
Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes.
Topics: Antimalarials; Candida; Cells, Cultured; Chloroquine; Drug Administration Schedule; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Mefloquine; Protein Biosynthesis; Pyrimethamine; Quinine; Quinolines; Tuberculin | 1987 |
Adaptation of the Indochina I/CDC strain of Plasmodium falciparum to the squirrel monkey (Saimiri sciureus).
Topics: Animals; Aotus trivirgatus; Cebidae; Chloroquine; Disease Models, Animal; Drug Resistance; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Saimiri; Splenectomy; Sulfadoxine | 1986 |
High level of sensitivity to chloroquine of 72 Plasmodium falciparum isolates from southern Cameroon in January 1985.
Topics: Animals; Antimalarials; Cameroon; Child; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1986 |
Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials.
Topics: Amino Acids; Ammonium Chloride; Animals; Antimalarials; Chloroquine; Erythrocytes; Host-Parasite Interactions; Humans; Mefloquine; Methylamines; Plasmodium falciparum; Quinine; Quinolines; Vacuoles | 1986 |
[Preliminary study, in vitro, of the sensitivity of P. falciparum to chloroquine, mefloquine and quinine during 1985, in Kampuchea].
Topics: Adult; Antimalarials; Cambodia; Chloroquine; Humans; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine; Quinolines | 1986 |
In vitro effect of chloroquine, mefloquine and quinine on human lymphocyte proliferative responses to malaria antigens and other antigens/mitogens.
Topics: Adult; Antigens, Fungal; Antigens, Protozoan; Candida albicans; Chloroquine; Humans; Lymphocyte Activation; Mefloquine; Mitogens; Plasmodium falciparum; Quinine; Quinolines; Tuberculin | 1986 |
Effects of combinations of quinoline-containing antimalarials on Plasmodium falciparum in culture.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Interactions; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1986 |
Chloroquine-resistant falciparum malaria from East Africa.
Topics: Adult; Africa, Eastern; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1986 |
Plasmodium falciparum drug resistance in West Africa.
Topics: Africa, Western; Animals; Antimalarials; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1986 |
[Development of P. falciparum sensitivity to chloroquine, to quinine and to mefloquine between 1983 and 1985 in Zaire].
Topics: Animals; Antimalarials; Chloroquine; Democratic Republic of the Congo; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1986 |
[Comparison of the effectiveness of two kinds of media for in vitro microtest of sensitivity of Plasmodium falciparum to chloroquine and mefloquine].
Topics: Animals; Chloroquine; Culture Media; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinolines | 1986 |
Plasmodium falciparum: S-adenosyl-L-methionine decarboxylase.
Topics: Adenosylmethionine Decarboxylase; Animals; Carboxy-Lyases; Chloroquine; Erythrocytes; Humans; Hydrogen-Ion Concentration; Kinetics; Mefloquine; Mitoguazone; Plasmodium falciparum; Polyamines; Putrescine; Quinolines | 1987 |
In vitro susceptibility of chloroquine resistant Plasmodium falciparum to mefloquine in Delhi.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Chloroquine; Drug Resistance; Humans; India; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines | 1986 |
Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
Topics: Adolescent; Adult; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Intestinal Absorption; Kinetics; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1987 |
[A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Meningoencephalitis; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1985 |
Use of non-human plasma for in vitro cultivation and antimalarial drug susceptibility testing of Plasmodium falciparum.
Topics: Animals; Antimalarials; Cattle; Chloroquine; Culture Media; Goats; Horses; Humans; Mefloquine; Plasma; Plasmodium falciparum; Quinolines; Sheep; Swine | 1985 |
Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; Lethal Dose 50; Malaria; Male; Mefloquine; Microbial Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Quinine; Quinolines; Thailand | 1985 |
Studies of resistance to chloroquine, quinine, amodiaquine and mefloquine among Philippine strains of Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Mefloquine; Philippines; Plasmodium falciparum; Quinine; Quinolines | 1985 |
Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.
Topics: Amodiaquine; Antimalarials; Chloroquine; Colombia; Drug Combinations; Drug Resistance, Microbial; Geography; Humans; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1985 |
Mefloquine failure in a case of falciparum malaria induced with a multidrug-resistant isolate in a non-immune subject.
Topics: Adult; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Male; Mefloquine; Phenanthrenes; Plasmodium falciparum; Pyridines; Quinine; Quinolines | 1985 |
Antimalarials increase vesicle pH in Plasmodium falciparum.
Topics: Ammonia; Animals; Antimalarials; Biological Transport; Chloroquine; Erythrocytes; Hydrogen-Ion Concentration; Lysosomes; Mefloquine; Organoids; Plasmodium falciparum; Quinine; Quinolines | 1985 |
[Studies on the chemoresistance of Plasmodium falciparum in Africa: current data].
Topics: Africa; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Mefloquine; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinolines | 1985 |
[Sensitivity of strains of Plasmodium falciparum to chloroquine, mefloquine and quinine in 1983 in Zaire].
Topics: Animals; Antimalarials; Chloroquine; Democratic Republic of the Congo; Drug Resistance, Microbial; In Vitro Techniques; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1985 |
In vitro response of Plasmodium falciparum to mefloquine. Studies conducted in West and East Africa.
Topics: Africa, Eastern; Africa, Western; Animals; Chloroquine; Drug Resistance, Microbial; In Vitro Techniques; Mefloquine; Plasmodium falciparum; Quinolines | 1985 |
Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Humans; Infant; Madagascar; Malaria; Mefloquine; Microbial Sensitivity Tests; Middle Aged; Phenanthrenes; Piperazines; Plasmodium falciparum; Quinine; Quinolines | 1985 |
[8 cases of drug-resistant Plasmodium falciparum malaria contracted in Mozambique].
Topics: Adult; Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria; Male; Mefloquine; Mozambique; Plasmodium falciparum; Quinolines | 1985 |
[Development of a piperaquine-resistant line of Plasmodium berghei K 173 strain].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Quinolines; Sesquiterpenes | 1985 |
In vitro assessment of sensitivity of Plasmodium falciparum to chloroquine and mefloquine in Ghana.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Female; Ghana; Humans; Malaria; Male; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinolines | 1985 |
[Malaria chemoprophylaxis. Resistance problems].
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1985 |
Recent trends of chemotherapy and vaccination against malaria: new lamps for old.
Topics: Antibodies, Monoclonal; Chloroquine; Drug Resistance, Microbial; Global Health; Humans; Immunotherapy; Malaria; Mefloquine; Plasmodium falciparum; Quinolines; Vaccines | 1985 |
A rabbit--in vitro system to evaluate drug action against Plasmodium falciparum.
Topics: Acedapsone; Animals; Antimalarials; Chloroquine; Drug Evaluation, Preclinical; Male; Mefloquine; Microbial Sensitivity Tests; Models, Biological; Plasmodium falciparum; Pyrimethamine; Quinolines; Rabbits; Time Factors; Triazines | 1983 |
Interactions of hemin, antimalarial drugs and hemin-antimalarial complexes with phospholipid monolayers.
Topics: Animals; Antimalarials; Cattle; Chloroquine; Heme; Hemin; Mathematics; Mefloquine; Membranes, Artificial; Phospholipids; Quinine; Quinolines; Surface Properties | 1984 |
The effect of anti-malarial drugs on human natural killer cells in vitro.
Topics: Antimalarials; Cell Line; Chloroquine; Cytotoxicity, Immunologic; Humans; Killer Cells, Natural; Leukemia, Myeloid, Acute; Mefloquine; Primaquine; Pyrimethamine; Quinacrine; Quinine; Quinolines | 1984 |
In vitro study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-micro test.
Topics: Antimalarials; Chloroquine; Evaluation Studies as Topic; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine; Quinolines | 1983 |
Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from Thailand.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; In Vitro Techniques; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Thailand | 1983 |
Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture.
Topics: Adaptation, Physiological; Animals; Antimalarials; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1983 |
Plasmodium falciparum-malaria: resistance to chloroquine, but sensitivity to mefloquine in the Gabon. A prospective in-vitro study.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Gabon; Humans; Infant; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Prospective Studies; Quinolines | 1984 |
The treatment of falciparum malaria.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium falciparum; Quinidine; Quinine; Quinolines; Sesquiterpenes | 1984 |
The relationship between the in vitro response of Plasmodium falciparum to chloroquine, quinine and mefloquine.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1984 |
Application of an in vitro semi-microtest to the study of drug sensitivity of 66 Plasmodium falciparum isolates from 15 countries.
Topics: Animals; Chloroquine; Drug Resistance, Microbial; Mefloquine; Microbial Sensitivity Tests; Piperazines; Plasmodium falciparum; Quinine; Quinolines | 1984 |
A comparative micro in-vitro test of P. falciparum to mefloquine and chloroquine in Gadchiroli District, Maharashtra State.
Topics: Animals; Antimalarials; Chloroquine; Humans; India; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinolines | 1984 |
[In vitro sensitivity tests of Plasmodium falciparum samples of the Amazonian Basin (Brazil)].
Topics: Amodiaquine; Animals; Antimalarials; Brazil; Chloroquine; In Vitro Techniques; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines | 1983 |
African serum interference in the determination of chloroquine sensitivity in Plasmodium falciparum.
Topics: Adult; Animals; Antimalarials; Child; Chloroquine; Drug Resistance, Microbial; Humans; Immune Sera; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sudan | 1984 |
[Drug sensitivity of Plasmodium falciparum in Madagascar. V. Study of the in vitro activity of quinine, mefloquine and halofantrine].
Topics: Antimalarials; Chloroquine; Humans; Mefloquine; Microbial Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Quinine; Quinolines | 1984 |
Inhibition of ornithine decarboxylase of in vitro cultured Plasmodium falciparum by chloroquine.
Topics: Carboxy-Lyases; Chloroquine; Culture; DNA; Eflornithine; Humans; Mefloquine; Ornithine; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Plasmodium falciparum; Quinolines | 1983 |
Diverse membrane-active agents modify the hemolytic response to ferriprotoporphyrin IX.
Topics: Adult; Antimalarials; Calcium; Chloroquine; Drug Synergism; Erythrocytes; Female; Heme; Hemin; Hemolysis; Humans; Male; Mefloquine; Osmotic Fragility; Quinine; Quinolines; Sodium Chloride | 1983 |
[Standardisation of the in vitro chemosensitivity test for Plasmodium falciparum ].
Topics: Antimalarials; Chloroquine; Drug Resistance, Microbial; Erythrocytes; Humans; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine; Quinolines | 1982 |
In vitro assessment of 2-acetylpyridine thiosemicarbazones against chloroquine-resistant Plasmodium falciparum.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Malaria; Mefloquine; Mice; Plasmodium falciparum; Pyrimethamine; Quinolines; Structure-Activity Relationship; Thiosemicarbazones | 1982 |
Plasmodium chabaudi-infection of mice: effects of chloroquine and mefloquine. Inhibition of ornithine decarboxylase activity.
Topics: Acridines; Animals; Antimalarials; Carboxy-Lyases; Chloroquine; Enzyme Repression; Erythrocyte Membrane; Malaria; Mefloquine; Mice; Ornithine Decarboxylase Inhibitors; Piperidines; Plasmodium; Primaquine; Quinolines | 1981 |
Antimalarial activity of mefloquine and chloroquine against blood induced Plasmodium knowlesi infection in rhesus monkeys.
Topics: Animals; Antimalarials; Chloroquine; Female; Macaca mulatta; Malaria; Male; Mefloquine; Piperidines; Quinolines | 1981 |
The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Erythrocytes; Male; Mefloquine; Mice; Piperidines; Plasmodium berghei; Pyrimethamine; Quinolines; Sulfadoxine | 1980 |
Binding of antimalarial drugs to hemozoin from Plasmodium berghei.
Topics: Animals; Antimalarials; Chloroquine; Heme; Hemeproteins; Mefloquine; Methemoglobin; Pigments, Biological; Piperidines; Plasmodium berghei; Protein Binding; Protoporphyrins; Quinacrine; Quinolines; Spectrophotometry | 1980 |
Decrease in susceptibility of Plasmodium falciparum to mefloquine in continuous culture.
Topics: Animals; Chloroquine; Culture Media; Drug Resistance, Microbial; Humans; In Vitro Techniques; Malaria; Mefloquine; Piperidines; Plasmodium falciparum; Quinolines | 1981 |
Use of the in vitro microtechnique for the assessment of drug sensitivity of Plasmodium falciparum in Sennar, Sudan.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Child; Child, Preschool; Chloroquine; Humans; In Vitro Techniques; Malaria; Mefloquine; Microbiological Techniques; Middle Aged; Piperidines; Plasmodium falciparum; Quinolines; Sudan | 1980 |
Sustained-release implants in the chemotherapy of experimental rodent malaria I. A comparison of the effects of some antimalarials in polydimethylsiloxane matrices.
Topics: Animals; Antimalarials; Chloroquine; Dimethylpolysiloxanes; Drug Implants; Malaria; Male; Mefloquine; Mice; Mice, Inbred Strains; Naphthoquinones; Piperidines; Plasmodium berghei; Primaquine; Proguanil; Pyrimethamine; Quinolines; Silicone Elastomers; Sulfadiazine; Triazines | 1981 |
In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Equatorial Guinea; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Regression Analysis; Sulfadoxine | 1995 |
The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Malaria; Mefloquine; Mice; Plasmodium yoelii; Stereoisomerism | 1995 |
Assessment of interactions of the antimalarial drugs chloroquine and mefloquine with NaNO2 and HgCl2 in rodents.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Chloroquine; Chromosome Aberrations; Dose-Response Relationship, Drug; Drug Interactions; Mefloquine; Mercuric Chloride; Mice; Mice, Inbred BALB C; Micronucleus Tests; Mitotic Index; Mutagenicity Tests; Mutagens; Rats; Rats, Wistar; Sodium Nitrite | 1994 |
Antimalarials for Africa.
Topics: Africa; Chloroquine; Humans; Malaria; Mefloquine; Travel; United Kingdom | 1994 |
Malaria prophylaxis. Mefloquine toxicity should limit its use to treatment alone.
Topics: Africa; Antimalarials; Chloroquine; Humans; Malaria; Malaria, Falciparum; Mefloquine; Proguanil; Travel | 1995 |
Malaria prophylaxis. Psychological problems after mefloquine and chloroquine.
Topics: Chloroquine; Humans; Malaria; Mefloquine; Mental Disorders | 1995 |
Quinine resistant falciparum malaria acquired in east Africa.
Topics: Adult; Africa, Eastern; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Male; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Tetracycline | 1995 |
Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; National Health Programs; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1994 |
[Malaria prevention with mefloquine].
Topics: Altitude Sickness; Calcium Channel Blockers; Chloroquine; Drug Interactions; Humans; Malaria; Mefloquine; Nifedipine | 1995 |
Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
[Development and trends from 1986 to 1993 of the attitude of intercontinental travellers on departure from France, with respect to malaria prophylaxis].
Topics: Africa South of the Sahara; Attitude to Health; Chloroquine; France; Humans; Malaria; Mefloquine; Mosquito Control; Proguanil; Risk Factors; Travel | 1993 |
Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay.
Topics: Animals; Antimalarials; Chloroquine; Colorimetry; Erythrocytes; Humans; L-Lactate Dehydrogenase; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Plasmodium vivax; Quinine | 1995 |
Confused malaria chemoprophylaxis.
Topics: Chloroquine; Clinical Protocols; Drug Resistance; Humans; Malaria; Mefloquine; Proguanil; Risk Factors; Travel; United Kingdom | 1994 |
[In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Mefloquine; Naphthyridines; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Northern; Blotting, Southern; Chloroquine; DNA Primers; DNA, Protozoan; Drug Resistance; Gene Amplification; Gene Expression; Genes, Protozoan; Mefloquine; Molecular Sequence Data; Phenanthrenes; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Quinine; RNA, Messenger; Selection, Genetic; Sequence Homology, Nucleic Acid; Sesquiterpenes | 1994 |
Ten-year surveillance of drug-resistant malaria in Burkina Faso (1982-1991).
Topics: Adolescent; Animals; Antimalarials; Burkina Faso; Child; Chloroquine; Drug Resistance; Humans; Longitudinal Studies; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prevalence; Pyrimethamine; Quinine; Retrospective Studies; Sulfadoxine | 1994 |
[Cytokines and malaria. A study of TNF-alpha, IL1-beta, IL6 and IL2R in 28 patients].
Topics: Adolescent; Adult; Amodiaquine; C-Reactive Protein; Chloroquine; Humans; Interleukin-1; Interleukin-6; Leukocyte Count; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Middle Aged; Neutrophils; Platelet Count; Prognosis; Receptors, Interleukin-2; Retrospective Studies; Tumor Necrosis Factor-alpha | 1994 |
Susceptibility of Plasmodium falciparum to chloroquine and mefloquine in Ouagadougou area (Burkina Faso).
Topics: Animals; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Evaluation; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Treatment Outcome | 1993 |
In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives.
Topics: Adult; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; Mefloquine; Naphthyridines; Phenanthrenes; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Triazines | 1994 |
Travellers' malaria risks.
Topics: Africa, Western; Chloroquine; Humans; Malaria; Mefloquine; Proguanil; Travel; United Kingdom | 1994 |
[Subacute Plasmodium falciparum malaria in 43 patients returning from areas with chloroquine in Africa].
Topics: Adult; Africa; Aged; Antibodies, Protozoan; Blood Cell Count; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Risk Factors; Time Factors; Travel | 1994 |
Sensitivity of Plasmodium falciparum field-isolates from Tanzania to chloroquine, mefloquine and pyrimethamine during in vitro cultivation.
Topics: Animals; Chloroquine; Drug Resistance; Mefloquine; Parasitology; Plasmodium falciparum; Pyrimethamine; Tanzania | 1993 |
Antimalarial chemoprophylaxis for west Africa.
Topics: Africa, Western; Antimalarials; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Patient Compliance; Proguanil | 1993 |
Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
Topics: Adult; Antimalarials; Chloroquine; Female; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Proguanil; Pyrimethamine; Sulfadoxine; Travel | 1993 |
Malaria chemoprophylaxis.
Topics: Chloroquine; Drug Combinations; Humans; Malaria; Mefloquine; Patient Compliance; Proguanil; Risk Factors; Travel | 1993 |
Malaria chemoprophylaxis.
Topics: Africa, Eastern; Africa, Western; Chloroquine; Drug Combinations; Humans; Malaria; Mefloquine; Patient Compliance; Proguanil; Risk Factors; Travel | 1993 |
Mefloquine prophylaxis.
Topics: Chloroquine; Humans; Malaria, Falciparum; Mefloquine | 1993 |
In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
Topics: Africa; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Mefloquine; Phenanthrenes; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Triazines | 1994 |
[A case of mefloquine-resistant Plasmodium falciparum malaria with convulsion after antimalarial treatment].
Topics: Adult; Animals; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Male; Mefloquine; Seizures; Travel; Uganda | 1994 |
Malaria chemoprophylactic regimens for travellers.
Topics: Chloroquine; Doxycycline; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Proguanil; Travel | 1994 |
Efficacy of chloroquine on Plasmodium falciparum transmitted at Amani, eastern Usambara Mountains, north-east Tanzania: an area where malaria has recently become endemic.
Topics: Adolescent; Adult; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up Studies; Hemoglobins; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinine; Regression Analysis; Sickle Cell Trait; Tanzania | 1993 |
Malaria prophylaxis. Mefloquine should be first choice.
Topics: Chloroquine; Humans; Malaria; Mefloquine; Proguanil | 1993 |
Warning--misleading malaria advice.
Topics: Chloroquine; Health Education; Humans; Malaria; Mefloquine; Pamphlets; Proguanil; South Africa | 1993 |
Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.
Topics: Adolescent; Animals; Child; Child, Preschool; Chloroquine; Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Desipramine; Drug Interactions; Drug Resistance, Microbial; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mixed Function Oxygenases; Plasmodium berghei; Plasmodium falciparum | 1993 |
In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Resistance; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 1993 |
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
Topics: Animals; Antimalarials; Aotus trivirgatus; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Malaria; Malaria, Falciparum; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1993 |
Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Erythrocytes; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Serial Passage; Vacuoles | 1993 |
Plasmodium falciparum: role of absolute stereochemistry in the antimalarial activity of synthetic amino alcohol antimalarial agents.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Mefloquine; Phenanthrenes; Plasmodium falciparum; Pyridines; Quinolines; Stereoisomerism; Structure-Activity Relationship | 1993 |
The antimalarial drug, Ro 42-1611 (arteflene), does not affect cytoadherence and cytokine-inducing properties of Plasmodium falciparum malaria parasites.
Topics: Adult; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Cell Survival; Chloroquine; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Humans; Immunoglobulin G; Interleukin-1; Interleukin-6; Lipopolysaccharides; Lymphocytes; Malaria, Falciparum; Mefloquine; Melanoma; Plasmodium falciparum; Styrenes; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1995 |
Canadian recommendations for the prevention and treatment of malaria among international travellers. Committee to Advise on Tropical Medicine and Travel (CATMAT).
Topics: Animals; Antimalarials; Canada; Child; Chloroquine; Culicidae; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Mefloquine; Pregnancy; Recurrence; Risk Factors; Travel | 1995 |
Malaria among United States troops in Somalia.
Topics: Anti-Bacterial Agents; Antimalarials; Chemoprevention; Chloroquine; Clothing; Cohort Studies; Doxycycline; Drug Resistance; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Population Surveillance; Prospective Studies; Protective Devices; Pyrimethamine; Quinine; Risk Factors; Somalia; Sulfadoxine; Treatment Failure; Treatment Refusal; United States | 1996 |
Effect of pH on in vitro potency of amantadine against Plasmodium falciparum.
Topics: Adamantane; Amantadine; Ammonium Chloride; Animals; Antimalarials; Chloroquine; Culture Media; Dose-Response Relationship, Drug; Drug Resistance; Humans; Hydrogen-Ion Concentration; Mefloquine; Plasmodium falciparum; Quinine | 1996 |
Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates.
Topics: Alleles; Animals; Antimalarials; Blotting, Southern; Cambodia; Chloroquine; Codon; DNA Fingerprinting; DNA, Protozoan; Drug Resistance, Multiple; Folic Acid Antagonists; Genes, Protozoan; Genetic Variation; Humans; Mefloquine; Phenanthrenes; Plasmodium falciparum; Polymorphism, Genetic; Proguanil; Pyrimethamine; Triazines | 1996 |
The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Fetal Growth Retardation; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Malaria, Falciparum; Malawi; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Risk Factors; Rural Population; Treatment Outcome | 1996 |
Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Fetal Death; Fever; Humans; Malaria, Falciparum; Malawi; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Rural Population | 1996 |
Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa.
Topics: Africa South of the Sahara; Alleles; Animals; Antimalarials; Base Sequence; Chloroquine; Codon; DNA Fingerprinting; DNA, Protozoan; Drug Resistance, Multiple; Genes, Protozoan; Genetic Variation; Humans; Malaria, Falciparum; Mefloquine; Phenotype; Plasmodium falciparum | 1995 |
[Informal care of malaria: determinants of demand and supply inventory. A study conducted in Touba City (Senegal)].
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Health Care Costs; Humans; Malaria; Male; Mefloquine; Middle Aged; Senegal; Surveys and Questionnaires | 1996 |
Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.
Topics: Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Health Surveys; Hospitalization; Humans; Malaria; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Proguanil; Retrospective Studies; Travel; Treatment Refusal; United Kingdom | 1996 |
In vitro drug sensitivity and clinical aspects of Plasmodium falciparum malaria in African children.
Topics: Animals; Child; Child, Preschool; Chloroquine; Congo; Humans; Infant; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Quinine | 1995 |
Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine.
Topics: Affinity Labels; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Binding, Competitive; Biological Transport, Active; Chloroquine; Drug Interactions; Drug Resistance, Multiple; Fluorescent Dyes; Humans; Kinetics; Mefloquine; Neoplasms; Prazosin; Tumor Cells, Cultured; Verapamil; Vinblastine | 1996 |
Adverse events associated with mefloquine. Study in returned travellers confirms authors' findings.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Humans; Mefloquine; Mental Disorders; Proguanil; Travel | 1996 |
Adverse events associated with mefloquine. Risk-benefit ratio must be taken into account.
Topics: Antimalarials; Chloroquine; Drug Combinations; Humans; Mefloquine; Mental Disorders; Proguanil; Risk Factors; Travel | 1996 |
In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh1.
Topics: Animals; Antimalarials; ATP-Binding Cassette Transporters; Biological Transport; Chloroquine; DNA Fingerprinting; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Gene Dosage; Gene Expression; Immunoblotting; Mefloquine; Phenanthrenes; Plasmodium falciparum; Protozoan Proteins; Quinine; Selection, Genetic; Sequence Analysis, DNA; Verapamil | 1996 |
High prevalence of chloroquine resistant Plasmodium falciparum infection in Rajasthan epidemic.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Chloroquine; Disease Outbreaks; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Immunoglobulin M; India; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Seroepidemiologic Studies; Sulfadoxine; Tumor Necrosis Factor-alpha | 1996 |
In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes; Vietnam | 1997 |
The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Drug Antagonism; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Malaria; Mefloquine; Mice; Naphthyridines; Parasitemia; Phenanthrenes; Phenylpropionates; Plasmodium berghei; Plasmodium yoelii | 1997 |
[Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Patient Compliance; Proguanil; Retrospective Studies | 1997 |
In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Humans; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tanzania | 1997 |
Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Mefloquine; Naphthyridines; Plasmodium falciparum; Quinacrine; Quinine | 1996 |
[There is no evidence of more symptoms with mefloquine than with other drugs in malaria prophylaxis].
Topics: Antimalarials; Chloroquine; Humans; Mefloquine; Proguanil | 1997 |
[Adverse effects associated with antimalarial chemoprophylaxis].
Topics: Adolescent; Adult; Aged; Antimalarials; Body Weight; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Humans; Male; Mefloquine; Middle Aged; Proguanil; Surveys and Questionnaires; Travel | 1997 |
Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa.
Topics: Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Humans; Kenya; Malaria; Male; Mefloquine; Patient Compliance; Proguanil; Senegal; Surveys and Questionnaires; Travel | 1997 |
Update on prevention of malaria for travelers.
Topics: Animals; Antimalarials; Chloroquine; Doxycycline; Drug Resistance; Global Health; Guidelines as Topic; Humans; Malaria; Mefloquine; Plasmodium; Primaquine; Proguanil; Travel | 1997 |
A simplified in vivo drug sensitivity test for malaria in the field.
Topics: Adult; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors | 1997 |
Pfmdr1 Asn1042Asp and Asp1246Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinine | 1998 |
On achieving consensus on the prevention of malaria.
Topics: Antimalarials; Chemoprevention; Chloroquine; Guidelines as Topic; Humans; Malaria, Falciparum; Mefloquine; Travel | 1998 |
In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Senegal; Sesquiterpenes | 1998 |
A primary malarial infection is composed of a very wide range of genetically diverse but related parasites.
Topics: Africa; Animals; Antimalarials; Biomarkers; Chloroquine; Clone Cells; Culicidae; Drug Resistance; Genetic Variation; Humans; Insect Bites and Stings; Malaria, Falciparum; Mefloquine; Parasitology; Phenotype; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinine; Thailand | 1998 |
New aspects of malaria imported from Ethiopia.
Topics: Animals; Antimalarials; Chloroquine; Culicidae; Disease Reservoirs; Drug Therapy, Combination; Ethiopia; Humans; Incidence; Insect Vectors; Israel; Malaria, Vivax; Mefloquine; Primaquine; Travel | 1998 |
Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Follow-Up Studies; Gabon; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes; Sulfadoxine | 1998 |
The effect of chemoprophylaxis on the timing of onset of falciparum malaria.
Topics: Antimalarials; Chemoprevention; Chloroquine; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Proguanil; Retrospective Studies; Time Factors; Travel | 1998 |
Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya.
Topics: Adult; Animals; Antimalarials; Case-Control Studies; Chloroquine; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Proguanil; Risk Factors; Travel | 1998 |
In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa).
Topics: Animals; Antimalarials; Burkina Faso; Chloroquine; Drug Resistance; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine | 1998 |
Mefloquine to prevent malaria. Withdrawal rates are misleading measure of tolerability.
Topics: Anti-Bacterial Agents; Antimalarials; Chloroquine; Doxycycline; Humans; Malaria; Mefloquine; Proguanil; Travel; Treatment Refusal | 1998 |
[Chemoprophylaxis of malaria in travelers to endemic zones].
Topics: Antimalarials; Chloroquine; Dapsone; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Proguanil; Pyrimethamine; Travel | 1998 |
Functional analysis of pfmdr1 gene of Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; CHO Cells; Cricetinae; Drug Resistance, Multiple; Genes, Protozoan; Mefloquine; Phenotype; Plasmodium falciparum; Recombinant Proteins; Transfection | 1998 |
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Chloroquine; Databases, Factual; Drug Combinations; Drug Industry; Female; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Proguanil; Prospective Studies; Pyrimethamine; Risk Factors; Safety; Sulfadoxine; Surveys and Questionnaires | 1998 |
[Considering disparities in resistance of Plasmodium falciparum in Africa in chemoprevention decisions].
Topics: Africa; Animals; Antimalarials; Chloroquine; Cross-Cultural Comparison; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Proguanil; Seasons; Travel; Triazines | 1998 |
Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthoquinones; Plasmodium falciparum; Plasmodium vivax; Primaquine; Proguanil; Pyrimethamine; Risk Assessment | 1998 |
Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols.
Topics: Amodiaquine; Antimalarials; Chloroquine; Hemoglobins; Humans; Leucine; Mefloquine; Phenanthrenes; Primaquine; Protease Inhibitors | 1998 |
In vitro susceptibility studies of Malaysian Plasmodium falciparum isolates and clones against schizontocidal drugs.
Topics: Animals; Antimalarials; Chloroquine; Malaysia; Mefloquine; Plasmodium falciparum; Quinine | 1998 |
A common mechanism for blockade of heme polymerization by antimalarial quinolines.
Topics: Animals; Antimalarials; Chloroquine; Erythrocytes; Heme; Hemeproteins; Mefloquine; Plasmodium falciparum; Polymers; Quinidine; Quinolines | 1998 |
Malaria at Christmas: risks of prophylaxis versus risks of malaria.
Topics: Adult; Antimalarials; Chloroquine; Disease Outbreaks; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Proguanil; Risk Factors; Travel; United Kingdom | 1998 |
Science commentary: protection against malaria.
Topics: Antimalarials; Chloroquine; Humans; Malaria; Mefloquine; Proguanil; Travel | 1998 |
A severe adverse reaction to mefloquine and chloroquine prophylaxis.
Topics: Adult; Antimalarials; Chloroquine; Drug Hypersensitivity; Humans; Malaria; Male; Mefloquine; Severity of Illness Index | 1998 |
8-Aminoquinolines active against blood stage Plasmodium falciparum in vitro inhibit hematin polymerization.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Hemin; Humans; Hydrogen-Ion Concentration; Mefloquine; Models, Molecular; Plasmodium falciparum; Quinolines | 1999 |
[The proper use of antimalarial drugs currently available].
Topics: Animals; Antimalarials; Chemoprevention; Chloroquine; Contraindications; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Plasmodium; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1998 |
[Pulmonary manifestations associated with malaria].
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Bronchitis; Child; Chloroquine; Female; Humans; Infant, Newborn; Lung Diseases; Malaria, Falciparum; Male; Mefloquine; Oxygen Inhalation Therapy; Phenanthrenes; Pleurisy; Pregnancy; Pregnancy Complications, Parasitic; Pulmonary Edema; Quinidine; Quinine; Respiratory Distress Syndrome, Newborn; Travel | 1998 |
Malaria prophylaxis for the 1990s and beyond.
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Proguanil | 1997 |
In vitro susceptibility of African Plasmodium falciparum isolates to dihydroartemisinin and the risk factors for resistance to qinghaosu.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chloroquine; Cross Reactions; Drug Evaluation, Preclinical; Drug Resistance; France; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Sesquiterpenes; Travel | 1998 |
Antimalarial drug resistance and combination chemotherapy.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Sesquiterpenes | 1999 |
Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
Topics: Adolescent; Adult; Animals; Antimalarials; Blood; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nigeria; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Random Allocation; Sulfadoxine | 1999 |
Plasmodium chabaudi: effect of antimalarial drugs on gametocytogenesis.
Topics: Animals; Antimalarials; Chloroquine; Gametogenesis; Malaria; Male; Mefloquine; Mice; Mice, Inbred C57BL; Plasmodium chabaudi; Pyrimethamine; Quinine | 1999 |
Phenotypic and genotypic characteristics of recently adapted isolates of Plasmodium falciparum from Thailand.
Topics: Animals; Antimalarials; Blotting, Western; Chloroquine; DNA Fingerprinting; DNA, Protozoan; Drug Resistance; Electrophoresis, Agar Gel; Gene Dosage; Genotype; Humans; Malaria, Falciparum; Mefloquine; Penfluridol; Phenanthrenes; Phenotype; Plasmodium falciparum; Polymerase Chain Reaction; Quinine; Thailand; Verapamil | 1999 |
The microculture tetrazolium assay (MTA): another colorimetric method of testing Plasmodium falciparum chemosensitivity.
Topics: Animals; Antimalarials; Chloroquine; Colorimetry; Dose-Response Relationship, Drug; Drug Resistance; L-Lactate Dehydrogenase; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Tetrazolium Salts | 1999 |
[Prevention of malaria].
Topics: Anti-Bacterial Agents; Antimalarials; Chloroquine; Doxycycline; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Proguanil; Risk Assessment; Risk Factors; Time Factors; Travel | 1999 |
Suboptimal prophylaxis for P. falciparum.
Topics: Antimalarials; Chloroquine; Fatal Outcome; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multiple Organ Failure; Treatment Failure | 1999 |
Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Chromosome Mapping; DNA Primers; DNA, Protozoan; Drug Resistance, Multiple; Electrophoresis, Agar Gel; Electrophoresis, Gel, Pulsed-Field; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Quinine; Scintillation Counting; Sequence Analysis, DNA; Thailand | 1999 |
Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Gambia; Hematocrit; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Quinine; Scintillation Counting; Sensitivity and Specificity; Sesquiterpenes | 1999 |
Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.
Topics: Animals; Antifungal Agents; Antimalarials; Cells, Cultured; Chloroquine; Clotrimazole; Growth Inhibitors; Histocytochemistry; Hypoxanthine; Mefloquine; Plasmodium falciparum | 2000 |
Prevention of malaria.
Topics: Antimalarials; Chloroquine; Doxycycline; Drug Resistance; Humans; Malaria; Mefloquine | 2000 |
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.
Topics: Amino Acid Substitution; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Cloning, Molecular; Drug Resistance; Mefloquine; Mutation; Phenanthrenes; Plasmodium falciparum; Protozoan Proteins; Quinine; Sesquiterpenes; Verapamil | 2000 |
Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro.
Topics: Amsacrine; Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Enzyme Inhibitors; Etoposide; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Naphthyridines; Norfloxacin; Nucleic Acid Synthesis Inhibitors; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Thailand; Topoisomerase II Inhibitors; Triazines | 2000 |
Management of a case of chloroquine-resistant falciparum malaria in a pregnant woman with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pyrimethamine | 1999 |
Prevention and treatment of malaria in UK travellers.
Topics: Age Factors; Antimalarials; Chloroquine; Contraindications; Doxycycline; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Proguanil; Quinine; Risk Factors; Travel | 2000 |
An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Humans; India; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
[Malaria imported to Norway 1989-98].
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Disease Notification; Emigration and Immigration; Female; Humans; Infant; Insect Bites and Stings; Malaria; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Norway; Proguanil; Travel | 2000 |
In vitro susceptibility of Plasmodium falciparum to four antimalarial drugs in the Central Province of Papua New Guinea.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; Mefloquine; Microbial Sensitivity Tests; Papua New Guinea; Phenanthrenes; Plasmodium falciparum; Quinine | 1998 |
Interaction of chloroquine and its analogues with heme: An isothermal titration calorimetric study.
Topics: Amodiaquine; Antimalarials; Binding Sites; Calorimetry; Chloroquine; Hemin; Hydrogen-Ion Concentration; Mefloquine; Octoxynol; Quinidine; Quinine; Solubility; Spectrophotometry, Ultraviolet; Temperature; Thermodynamics; Titrimetry | 2000 |
Treatment of uncomplicated Plasmodium falciparum malaria in Myanmar: a clinical decision analysis.
Topics: Antimalarials; Chloroquine; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2000 |
Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys.
Topics: Adaptation, Physiological; Adult; Amodiaquine; Animals; Antimalarials; Aotidae; Child; Chloroquine; Disease Models, Animal; Drug Resistance; Female; Humans; Indonesia; Malaria, Vivax; Male; Mefloquine; Parasitemia; Plasmodium vivax; Saimiri; Splenectomy | 2000 |
Coadministration of mefloquine and chloroqine: use of a pharmacokinetic-based approach to reduce toxicity.
Topics: Antimalarials; Child; Chloroquine; Drug Overdose; Drug Synergism; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine | 2001 |
Vivax malaria: also a challenge to biomedical sciences and services.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria, Vivax; Mefloquine; Plasmodium vivax; Primaquine | 1999 |
Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Gabon; Humans; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Practice Guidelines as Topic; Prospective Studies; Quinine | 2001 |
Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Confidence Intervals; Drug Resistance; Drug Therapy, Combination; Humans; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes; Statistics, Nonparametric | 2001 |
Use of the DELI-microtest to determine the drug sensitivity of Plasmodium falciparum in Burkina Faso.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Malaria, Falciparum; Mefloquine; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Reagent Kits, Diagnostic; Sensitivity and Specificity; Statistics, Nonparametric | 2001 |
Reversal of chloroquine and mefloquine resistance in Plasmodium falciparum by the two monoindole alkaloids, icajine and isoretuline.
Topics: Alkaloids; Animals; Antimalarials; Chloroquine; Colon; Drug Resistance, Multiple; Drug Synergism; Humans; Indoles; Inhibitory Concentration 50; Mefloquine; Molecular Structure; Plasmodium falciparum; Strychnine; Tumor Cells, Cultured | 2001 |
Death from malaria following inappropriate chemoprophylaxis.
Topics: Africa; Animals; Antimalarials; Centers for Disease Control and Prevention, U.S.; Chemoprevention; Child; Chloroquine; Drug Resistance; Fatal Outcome; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Travel; United States | 2001 |
Antimalarial drugs clear resistant parasites from partially immune hosts.
Topics: Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Resistance; Immunization; Malaria; Mefloquine; Mice; Plasmodium chabaudi | 2001 |
In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes | 2001 |
Malaria remains a military medical problem.
Topics: Adult; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Global Health; Humans; Kenya; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Medicine; Military Personnel; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Plasmodium vivax; Proguanil; Sierra Leone; Treatment Failure; Treatment Outcome; United Kingdom | 2001 |
Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
Topics: Animals; Antimalarials; Chloroquine; Erythrocytes; Hemoglobins; Mefloquine; Plasmodium falciparum | 2002 |
Efficacy of scopadulcic acid A against Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Chloroquine; Diterpenes; Drug Resistance; Humans; In Vitro Techniques; Inhibitory Concentration 50; Mefloquine; Plants, Medicinal; Plasmodium falciparum; Scrophulariaceae | 2002 |
Design, synthesis, and evaluation of new chemosensitizers in multi-drug-resistant Plasmodium falciparum.
Topics: Animals; Antimalarials; Cell Line; Chloroquine; Diphenylamine; Drug Resistance, Multiple; Imines; Mefloquine; Molecular Conformation; Phenothiazines; Plasmodium falciparum; Pyrrolidines; Stilbenes; Structure-Activity Relationship | 2002 |
Resistant malaria in a neonate.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant, Newborn; Malaria, Falciparum; Mefloquine; Quinine; Risk Assessment; Sesquiterpenes; Severity of Illness Index; Treatment Outcome | 2002 |
[Many travellers suffer of side-effects of malaria prophylaxis].
Topics: Antimalarials; Chloroquine; Drug Eruptions; Gastrointestinal Diseases; Humans; Malaria; Mefloquine; Mental Disorders; Proguanil; Surveys and Questionnaires; Travel | 2002 |
Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitro.
Topics: Animals; Antimalarials; Chloroquine; Erythrocytes; Fibroblasts; Flurazepam; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hemeproteins; Humans; Isoquinolines; Ligands; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Toxoplasma | 2002 |
Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Cloning, Molecular; Drug Resistance; Genes, Protozoan; Haplotypes; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Parasitic Sensitivity Tests; Phenotype; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Quinine; Sesquiterpenes; Transfection; Verapamil | 2002 |
Haem polymerase as a novel target of antimalarial action of cyproheptadine.
Topics: Animals; Antimalarials; Chloroquine; Cyproheptadine; Disease Models, Animal; Drug Resistance; Enzyme Inhibitors; Hemeproteins; Mefloquine; Mice; Plasmodium yoelii; Quinine; Transferases; Treatment Outcome | 2002 |
Molecular characterisation of drug-resistant Plasmodium falciparum from Thailand.
Topics: Amodiaquine; Animals; Antimalarials; ATP-Binding Cassette Transporters; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Gene Frequency; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Thailand | 2002 |
Discovery of novel targets of quinoline drugs in the human purine binding proteome.
Topics: Adenosine Triphosphate; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Antimalarials; Chloroquine; Chromatography, Agarose; Enzyme Inhibitors; Erythrocytes; Humans; Isoenzymes; Mefloquine; Mice; NAD(P)H Dehydrogenase (Quinone); Plasmodium falciparum; Primaquine; Proteome; Retinal Dehydrogenase; Sepharose | 2002 |
Drug-resistant Plasmodium falciparum infection in immigrants and non-immune travellers.
Topics: Adult; Africa; Animals; Antimalarials; Asia, Southeastern; Chloroquine; Drug Resistance; Emigration and Immigration; Female; Humans; Inhibitory Concentration 50; Kuwait; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Travel | 2002 |
In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Gabon; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Quinine | 2003 |
[Assay of sensitivity of Plasmodium falciparum to chloroquine, amodiaquine, piperaquine, mefloquine and quinine in Yunnan province].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1999 |
Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; France; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Quinine; Triazines | 2002 |
In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
Topics: Animals; Antimalarials; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Hospitals, Public; Hospitals, Urban; Humans; Madagascar; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Quinine; Rural Health | 2002 |
Drug-resistant malaria in Bangladesh: an in vitro assessment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Bangladesh; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes | 2003 |
In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Madagascar; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Triazines | 2002 |
Malaria in Austria 1990-2000.
Topics: Adolescent; Adult; Age Distribution; Animals; Austria; Chemoprevention; Child; Child, Preschool; Chloroquine; Disease Notification; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Patient Compliance; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Sex Distribution; Sulfadoxine | 2003 |
Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupéla District, Burkina Faso.
Topics: Adolescent; Adult; Animals; Antimalarials; Burkina Faso; Chemoprevention; Chloroquine; Cross-Sectional Studies; Culicidae; Disease Vectors; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Insecticides; Malaria, Falciparum; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Treatment Outcome | 2003 |
[Malaria--case report].
Topics: Adult; Anti-Infective Agents; Antidiarrheals; Antimalarials; Chloroquine; Ciprofloxacin; Diarrhea; Emergencies; Fluid Therapy; Glasgow Coma Scale; Humans; Loperamide; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Nigeria; Parasitemia; Positive-Pressure Respiration; Proguanil; Quinine; Respiratory Distress Syndrome; Travel | 2003 |
The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Mice; Plasmodium berghei; Plasmodium chabaudi; Plasmodium yoelii; Primaquine; Time Factors | 2003 |
Mapping of the Plasmodium falciparum multidrug resistance gene 5'-upstream region, and evidence of induction of transcript levels by antimalarial drugs in chloroquine sensitive parasites.
Topics: 5' Untranslated Regions; Animals; Antimalarials; ATP-Binding Cassette Transporters; Base Sequence; Chloroquine; Chromosome Mapping; Drug Resistance, Multiple; Gene Expression Regulation; Genes, MDR; Genes, Protozoan; Genes, Reporter; Luciferases; Mefloquine; Molecular Sequence Data; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Quinine; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Sequence Homology, Nucleic Acid; Transcription, Genetic | 2003 |
Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for the transmission of drug-resistant parasites.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Recurrence; Statistics as Topic; Sulfadoxine; Treatment Failure | 2003 |
Delayed onset of malaria--implications for chemoprophylaxis in travelers.
Topics: Antimalarials; Chloroquine; Drug Resistance; Endemic Diseases; Humans; Israel; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Population Surveillance; Time Factors; Travel; United States | 2003 |
Diagnosis and treatment of malaria in children.
Topics: Animals; Antimalarials; Atovaquone; Child; Chloroquine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
A cost-effectiveness analysis of three antimalarial treatments for acute, uncomplicated Plasmodium falciparum malaria in Mumbai, India.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Combinations; Economics, Pharmaceutical; Ethanolamines; Female; Fluorenes; Hospitalization; Humans; India; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 2003 |
Malaria during pregnancy in a reference centre from the Brazilian Amazon: unexpected increase in the frequency of Plasmodium falciparum infections.
Topics: Adolescent; Adult; Antimalarials; Brazil; Child; Chloroquine; Cross-Sectional Studies; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Quinine | 2004 |
Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; DNA Damage; DNA Repair; Drug Resistance; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfanilamide; Sulfanilamides; Ultraviolet Rays | 2004 |
In vitro susceptibility of Plasmodium falciparum isolates to chloroquine and mefloquine in southeastern Mindanao Island, the Philippines.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Female; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Mefloquine; Parasitic Sensitivity Tests; Philippines; Plasmodium falciparum; Residence Characteristics | 2003 |
Polymorphism of the Plasmodium falciparum multidrug resistance and chloroquine resistance transporter genes and in vitro susceptibility to aminoquinolines in isolates from the Peruvian Amazon.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Genes, MDR; Genotype; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2004 |
Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum.
Topics: Ammonium Chloride; Animals; Antimalarials; Artemisinins; Biotin; Blotting, Western; Chloroquine; Dextrans; Endocytosis; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Hemoglobins; Mefloquine; Microscopy, Electron; Microscopy, Fluorescence; Monensin; Plasmodium falciparum; Quinolones; Sesquiterpenes; Transport Vesicles; Vacuoles | 2004 |
Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts.
Topics: Animals; Antimalarials; Chloroquine; Mefloquine; Molecular Conformation; Molecular Structure; Plasmodium falciparum; Quinine; Structure-Activity Relationship | 2004 |
The in-vitro antimalarial activity of ferrochloroquine, measured against Cambodian isolates of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Sesquiterpenes | 2004 |
The sensitivities of yeast strains deficient in PDR ABC transporters, to quinoline-ring antimalarial drugs.
Topics: Antimalarials; ATP-Binding Cassette Transporters; Chloroquine; Cycloheximide; Drug Resistance, Multiple, Fungal; Gene Deletion; Genes, Fungal; Mefloquine; Mutation; Quinacrine; Quinidine; Quinine; Saccharomyces cerevisiae; Transcription, Genetic | 2004 |
[Acute malaria in an Israeli tourist to Kenya].
Topics: Acidosis; Adult; Chloroquine; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Treatment Outcome | 1999 |
In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Sesquiterpenes; Statistics, Nonparametric | 2005 |
Efficacy of antimalarial chemoprophylaxis among French residents travelling to Africa.
Topics: Adult; Africa South of the Sahara; Africa, Western; Antimalarials; Case-Control Studies; Chloroquine; Drug Therapy, Combination; Female; France; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Compliance; Proguanil; Travel; Treatment Outcome | 2005 |
Absence of nucleotide polymorphism in a Plasmodium vivax multidrug resistance gene after failure of mefloquine prophylaxis in French Guyana.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Humans; Malaria, Vivax; Male; Mefloquine; Military Personnel; Mutation; Plasmodium vivax; Polymorphism, Single Nucleotide | 2005 |
Syndromic management of prolonged fever: a cost-effective approach.
Topics: Anti-Infective Agents; Antimalarials; Chloramphenicol; Chloroquine; Cost-Benefit Analysis; Drug Therapy, Combination; Fever; Humans; Infant; Mefloquine; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
ATPase activity of purified plasma membranes and digestive vacuoles from Plasmodium falciparum.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Artemisinins; Cell Membrane; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinine; Sesquiterpenes; Subcellular Fractions; Vacuoles | 2005 |
Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand.
Topics: Animals; Antimalarials; ATP-Binding Cassette Transporters; Biomarkers; Chloroquine; Drug Resistance; Endemic Diseases; Genes, MDR; Genotype; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Thailand | 2005 |
In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Sesquiterpenes; Thailand; Time Factors | 2005 |
[Malaria prophylaxis for long-term travellers and expatriates].
Topics: Antimalarials; Atovaquone; Chloroquine; Counseling; Doxycycline; Drug Combinations; Humans; Insect Bites and Stings; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Proguanil; Risk Assessment; Risk Factors; Travel | 2005 |
In vitro susceptibility and genetic variations for chloroquine and mefloquine in Plasmodium falciparum isolates from Thai-Myanmar border.
Topics: Animals; Chloroquine; Disease Susceptibility; Drug Resistance, Microbial; Genetic Variation; Humans; In Vitro Techniques; Malaria; Mefloquine; Mutation; Myanmar; Plasmodium falciparum; Polymorphism, Genetic; Risk Factors; Thailand | 2005 |
Mefloquine-induced mania in a 22-year-old Chinese man.
Topics: Acute Disease; Adult; Animals; Antimalarials; Bipolar Disorder; Chloroquine; Contraindications; Humans; Malaria, Falciparum; Male; Mefloquine; Nonprescription Drugs; Risk Factors; Risperidone; Singapore | 2006 |
In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan.
Topics: Animals; Antimalarials; Chloroquine; In Vitro Techniques; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Sudan; Sulfadoxine | 2006 |
Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor.
Topics: 1-Octanol; Animals; Carbenoxolone; Central Nervous System Stimulants; Cerebellum; Chloroquine; Connexins; Disease Models, Animal; Dose-Response Relationship, Drug; Essential Tremor; Female; Gap Junction delta-2 Protein; Gap Junctions; Glycyrrhizic Acid; Harmaline; Heptanol; Injections, Subcutaneous; Mefloquine; Mice; Mice, Inbred ICR; Olivary Nucleus | 2006 |
Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis.
Topics: Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Loperamide; Mefloquine; Mental Disorders; Psychotic Disorders | 2006 |
Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Cells, Cultured; Chloroquine; Drug Resistance, Multiple; Drug Synergism; Erythrocytes; Fluoxetine; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2006 |
Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Chloroquine; Drug Synergism; HIV Protease Inhibitors; Humans; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Ritonavir; Saquinavir | 2007 |
Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Synergism; Inhibitory Concentration 50; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Roxithromycin | 2007 |
[A plasmodium alciparum malaria case originated from Mozambique: clues for the diagnosis and therapy].
Topics: Animals; Antimalarials; Canada; Chloroquine; Doxycycline; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Mozambique; Parasitemia; Plasmodium falciparum; Quinine; Secondary Prevention; Travel; Turkey | 2006 |
Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approach.
Topics: Algorithms; Animals; Antimalarials; Artemisinins; Artesunate; Bayes Theorem; Chloroquine; Computer Simulation; Dose-Response Relationship, Drug; Drug Resistance; False Positive Reactions; Inhibitory Concentration 50; Mefloquine; Models, Biological; Phenanthrenes; Plasmodium falciparum; Sesquiterpenes | 2007 |
In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Sesquiterpenes | 2007 |
A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Chloroquine; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Glutathione; Heme; Indicators and Reagents; Mefloquine; Methylene Blue; o-Phthalaldehyde; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Spectrometry, Fluorescence | 2007 |
The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptors.
Topics: Algorithms; Animals; Antimalarials; Binding, Competitive; Cells, Cultured; Chloroquine; Dose-Response Relationship, Drug; Electrophysiology; Female; Granisetron; In Vitro Techniques; Kinetics; Mefloquine; Models, Molecular; Oocytes; Quinine; Radioligand Assay; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Xenopus laevis | 2007 |
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Resistance; Ghana; Humans; Infant; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 2007 |
Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; DNA, Protozoan; Drug Resistance; Humans; Inhibitory Concentration 50; Madagascar; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Protozoan Proteins; Quinine; Rural Population | 2007 |
Adaptation of a multi-drug resistant strain of Plasmodium falciparum from Peru to Aotus lemurinus griseimembra, A. nancymaae, and A. vociferans monkeys.
Topics: Animals; Antimalarials; Aotidae; Chloroquine; Cytochromes b; Dihydropteroate Synthase; Disease Models, Animal; DNA, Protozoan; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Monkey Diseases; Parasitemia; Peru; Plasmodium falciparum; Sequence Analysis, DNA; Tetrahydrofolate Dehydrogenase | 2007 |
[Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Colombia; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins | 2007 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
Clinical inquiries. When should travelers begin malaria prophylaxis?
Topics: Antimalarials; Chloroquine; Contraindications; Doxycycline; Humans; Insect Repellents; Insecticides; Internet; Malaria; Mefloquine; Occlusive Dressings; Permethrin; Practice Guidelines as Topic; Primaquine; Time Factors; Travel | 2007 |
Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand.
Topics: Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Lethal Dose 50; Malaria, Vivax; Mefloquine; Plasmodium vivax; Survival Rate; Thailand; Treatment Outcome | 2007 |
Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
Topics: Algorithms; Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Computer Simulation; Drug Resistance; Malaria; Mefloquine; Models, Theoretical; Pyrimethamine; Quinine | 2008 |
Antimalarial drugs inhibit human 5-HT(3) and GABA(A) but not GABA(C) receptors.
Topics: Animals; Antimalarials; Binding, Competitive; Cells, Cultured; Chloroquine; Electrophysiology; Female; GABA-A Receptor Antagonists; Humans; Inhibitory Concentration 50; Mefloquine; Oocytes; Quinine; Receptors, GABA; Serotonin 5-HT3 Receptor Antagonists; Xenopus laevis | 2008 |
Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Blotting, Western; Chloroquine; Endocytosis; Erythrocytes; Hemoglobins; Humans; Mefloquine; Peroxidase; Phenanthrenes; Plasmodium falciparum; Protein Binding; Protozoan Proteins; Quinolines | 2008 |
Malaria in Egypt, Saudi Arabia and Yemen: a clinical pilot study.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Egypt; Female; Humans; Infant; Malaria; Male; Mefloquine; Middle Aged; Pilot Projects; Quinine; Saudi Arabia; Severity of Illness Index; Yemen | 2007 |
Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Colombia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Protozoan Proteins | 2008 |
In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.
Topics: Aminoquinolines; Amodiaquine; Animals; Chloroquine; Drug Resistance, Bacterial; Ferrous Compounds; Mefloquine; Membrane Transport Proteins; Metallocenes; Microsatellite Repeats; Molecular Structure; Plasmodium falciparum; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines | 2008 |
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites | 2009 |
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Chloroquine; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Survival Analysis; Treatment Failure | 2009 |
Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.
Topics: Animals; Antimalarials; Artemisinins; Benzothiazoles; Chloroquine; Diamines; Drug Combinations; Drug Evaluation, Preclinical; Drug Interactions; Fluorescent Dyes; Hypoxanthine; Mefloquine; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2009 |
Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Thailand | 2009 |
Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Gene Dosage; Genetic Markers; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Thailand | 2010 |
Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance, Bacterial; Geographic Information Systems; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Oligonucleotide Array Sequence Analysis; Plasmodium falciparum; Point Mutation; Polymorphism, Single Nucleotide; Quinine | 2010 |
Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent.
Topics: Antineoplastic Agents; Autophagy; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Chloroquine; Glioma; Humans; Immunohistochemistry; Mefloquine; Quinacrine; Tumor Suppressor Protein p53; Vacuoles | 2010 |
Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene.
Topics: Amodiaquine; Antimalarials; Atorvastatin; Chloroquine; DNA, Protozoan; Drug Synergism; Gene Dosage; Genotype; Heptanoic Acids; Humans; Inhibitory Concentration 50; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrroles | 2010 |
Purified Plasmodium falciparum multi-drug resistance protein (PfMDR 1) binds a high affinity chloroquine analogue.
Topics: Antimalarials; Binding Sites; Chloroquine; Drug Resistance, Multiple; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protein Binding; Quinine | 2010 |
Residual antimalarial concentrations before treatment in patients with malaria from Cambodia: indication of drug pressure.
Topics: Adolescent; Adult; Antimalarials; Cambodia; Child; Child, Preschool; Chloroquine; Chromatography, Liquid; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinine; Quinolines; Selection, Genetic; Serum; Tandem Mass Spectrometry; Young Adult | 2010 |
In-vitro culture of Plasmodium falciparum: utility of modified (RPNI) medium for drug-sensitivity studies using SYBR Green I assay.
Topics: Antimalarials; Artemether; Artemisinins; Benzothiazoles; Chloroquine; Culture Media; Diamines; Fluorescent Dyes; Mefloquine; Organic Chemicals; Plasmodium falciparum; Quinine; Quinolines | 2011 |
Potentiation of the mutagenicity and recombinagenicity of bleomycin in yeast by unconventional intercalating agents.
Topics: Amines; Animals; Benzophenones; Bleomycin; Cell Line; Chloroquine; Chlorpromazine; Cricetinae; DNA Damage; Drug Synergism; Gene Conversion; Intercalating Agents; Mefloquine; Mutagenicity Tests; Mutagens; Recombination, Genetic; Saccharomyces cerevisiae; Tamoxifen | 2011 |
Enantiomeric separation of antimalarial drugs by capillary electrophoresis using neutral and negatively charged cyclodextrins.
Topics: Aminoquinolines; Anions; Antimalarials; beta-Cyclodextrins; Chloroquine; Cyclodextrins; Electrophoresis, Capillary; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mefloquine; Primaquine; Stereoisomerism | 2011 |
Suicide by skull stab wounds: a case of drug-induced psychosis.
Topics: Adult; Antimalarials; Arm Injuries; Chloroquine; Forensic Toxicology; Gastrointestinal Contents; Head Injuries, Penetrating; Humans; Male; Mefloquine; Psychoses, Substance-Induced; Shoulder; Shoulder Injuries; Suicide; Temporal Lobe; Wounds, Stab | 2010 |
Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies.
Topics: Animals; Antimalarials; Cell Line, Tumor; Chlorocebus aethiops; Chloroquine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA; Drug Resistance; Erythrocytes; Hemin; Humans; Indole Alkaloids; Mefloquine; Oligonucleotides; Plasmodium falciparum; Pyrimethamine; Quinolines; Structure-Activity Relationship; Vero Cells | 2011 |
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins | 2011 |
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
Topics: Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Erythrocytes; Humans; Imidazoles; Indoles; Inhibitory Concentration 50; Mefloquine; p38 Mitogen-Activated Protein Kinases; Plasmodium falciparum; Protein Kinase Inhibitors; Pyridines | 2011 |
In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Chloroquine; Ethanolamines; Fluorenes; Inhibitory Concentration 50; Lumefantrine; Mefloquine; Methylene Blue; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2011 |
2,4-diarylthiazole antiprion compounds as a novel structural class of antimalarial leads.
Topics: Antimalarials; Chloroquine; Mefloquine; Molecular Structure; Plasmodium falciparum; Prions; Quinacrine; Structure-Activity Relationship; Thiazoles | 2011 |
Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta).
Topics: Aminoquinolines; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Chromatography, Liquid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Macaca mulatta; Malaria; Male; Mass Spectrometry; Mefloquine; Plasma; Plasmodium cynomolgi; Primate Diseases; Quinine; Treatment Outcome | 2011 |
Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Lethal Dose 50; Mefloquine; Plasmodium vivax; Thailand | 2011 |
Quality of essential drugs in tropical countries: evaluation of antimalarial drugs in the Brazilian Health System.
Topics: Antimalarials; Brazil; Chloroquine; Chromatography, High Pressure Liquid; Drug Storage; Drugs, Essential; Humans; Mefloquine; Primaquine; Quality Control; Quinine | 2011 |
Eritrean and Sudanese migrants presenting with malaria in Israel.
Topics: Adult; Antigens, Protozoan; Antimalarials; Chloroquine; Eritrea; Female; Hospitalization; Humans; Israel; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Population Surveillance; Retrospective Studies; Sudan; Transients and Migrants; Treatment Outcome; Young Adult | 2011 |
Prophylactic use of antimalarials during pregnancy.
Topics: Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Doxycycline; Drug Combinations; Female; Humans; Hydroxychloroquine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Proguanil; Travel | 2011 |
Extracellular heme enhances the antimalarial activity of artemisinin.
Topics: Antimalarials; Antioxidants; Artemisia; Artemisinins; Chloroquine; Cholesterol, LDL; Fluorescence; Heme; Hemin; Humans; Lipid Peroxidation; Mefloquine; Oxidants; Oxidation-Reduction; Plasmodium falciparum; Quinine; Tryptophan; Vitamin E | 2012 |
Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
Topics: Aminoquinolines; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evolution, Molecular; Fluorenes; French Guiana; Gene Dosage; Haplotypes; Humans; Inhibitory Concentration 50; Longitudinal Studies; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Practice Guidelines as Topic; Protozoan Proteins; Quinine | 2012 |
Anti-malarial chemoprophylaxis following evacuation from Afghanistan.
Topics: Afghan Campaign 2001-; Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Clinical Audit; Doxycycline; Drug Combinations; Drug Prescriptions; Humans; Malaria; Mefloquine; Military Personnel; Proguanil | 2012 |
Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2012 |
In vitro assessment of drug resistance in Plasmodium falciparum in five States of India.
Topics: Amodiaquine; Artemisinins; Artesunate; Biomarkers, Pharmacological; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; India; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins | 2012 |
Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines; Treatment Outcome; Young Adult | 2013 |
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Erythrocytes; Flow Cytometry; High-Throughput Screening Assays; Hydroxamic Acids; Inhibitory Concentration 50; Mefloquine; Merozoites; Plasmodium falciparum; Quinine; Quinolines; Schizonts; Time Factors | 2013 |
Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Humans; Ketoconazole; Liver; Malaria; Male; Mefloquine; Mice; Plasmodium falciparum; Plasmodium yoelii; Quinine | 2013 |
An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines.
Topics: Acute Disease; Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Genotype; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Haptoglobins; Hemolytic Agents; Male; Mefloquine; Mice; Phenotype; Primaquine; Reticulocyte Count | 2013 |
Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
Topics: Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Boron Compounds; Chloroquine; Chlorpheniramine; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Erythrocytes; Fluorescent Dyes; Gefitinib; Humans; Imatinib Mesylate; Mefloquine; Piperazines; Plasmodium falciparum; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinolines | 2013 |
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
Topics: Amodiaquine; Antimalarials; Artemisinins; Automation, Laboratory; Chloroquine; Drug Resistance; Drug Therapy, Combination; High-Throughput Screening Assays; Internet; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine | 2013 |
The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
Topics: Amodiaquine; Antimalarials; Chloroquine; DNA, Protozoan; Drug Resistance; Ethanolamines; Fluorenes; Haplotypes; Humans; Inhibitory Concentration 50; Kenya; Lumefantrine; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Retrospective Studies | 2013 |
In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon.
Topics: Adolescent; Adult; Antimalarials; Brazil; Cell Survival; Child; Chloroquine; Female; Humans; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Malaria, Vivax; Male; Mefloquine; Middle Aged; Mutation, Missense; Parasitic Sensitivity Tests; Plasmodium vivax; Protozoan Proteins; Young Adult | 2013 |
Nonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparum.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Ethanolamines; Fluorenes; Lumefantrine; Mefloquine; Models, Statistical; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Protozoan Proteins | 2013 |
Repeat polymorphisms in the low-complexity regions of Plasmodium falciparum ABC transporters and associations with in vitro antimalarial responses.
Topics: Amino Acid Motifs; Antimalarials; Artemisinins; Asparagine; Aspartic Acid; Chloroquine; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Genome, Protozoan; Lumefantrine; Mefloquine; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2013 |
Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
Topics: Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug; Doxycycline; Drug Evaluation, Preclinical; Erythrocyte Count; Erythrocyte Transfusion; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Mefloquine; Mice; Mice, Inbred NOD; Mice, SCID; Primaquine; Pyrimethamine; Reproducibility of Results; Sensitivity and Specificity; Transplantation, Heterologous | 2013 |
Formulation and evaluation of Pheroid vesicles containing mefloquine for the treatment of malaria.
Topics: Animals; Biological Availability; Cell Line, Tumor; Chemistry, Pharmaceutical; Chloroquine; Coated Vesicles; Drug Delivery Systems; Half-Life; Humans; Malaria; Male; Mefloquine; Mice; Mice, Inbred C57BL; Neuroblastoma; Particle Size; Solubility | 2014 |
Susceptibility of human Plasmodium knowlesi infections to anti-malarials.
Topics: Animals; Antimalarials; Artemisinins; Borneo; Chloroquine; Humans; Malaria; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium knowlesi; Plasmodium vivax; Zoonoses | 2013 |
Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
Topics: Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chloroquine; Doxycycline; Drug Resistance, Neoplasm; Humans; Mefloquine; Primaquine; Verapamil; Vinblastine | 2013 |
Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Resistance; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Seasons; Thailand; Time Factors | 2014 |
Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro.
Topics: Animals; Antimalarials; Central Nervous System Stimulants; Chloroquine; CHO Cells; Cricetinae; Cricetulus; Hallucinogens; HEK293 Cells; Humans; Mefloquine; Mice; Receptors, Dopamine; Receptors, Serotonin; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism | 2014 |
Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Brazil; Chloroquine; DNA, Protozoan; Drug Resistance; Female; Genotype; Humans; Inhibitory Concentration 50; Malaria; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation, Missense; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins | 2014 |
Imported malaria is stable from Africa but declining from Asia.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Asia; Atovaquone; Chemoprevention; Child; Child, Preschool; Chloroquine; Delayed Diagnosis; Denmark; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Primaquine; Proguanil; Recurrence; Risk Factors; Severity of Illness Index; Travel; Young Adult | 2014 |
Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar.
Topics: Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Chloroquine; Drug Resistance; Ethanolamines; Fluorenes; Geography; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Mutation; Myanmar; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Selection, Genetic; Sequence Analysis, DNA | 2014 |
Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
Topics: Animals; Antimalarials; Artemisinins; Cell Line; Cell Survival; Cells, Cultured; Chloroquine; Doxycycline; Drug Synergism; Drug Therapy, Combination; Erythrocytes; Humans; Interleukin-10; Interleukin-4; Malaria, Cerebral; Mefloquine; Mice; Mice, Inbred C57BL; Monocytes; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium berghei; Plasmodium falciparum | 2014 |
Imported malaria in a non-endemic area: the experience of the university of Campinas hospital in the Brazilian Southeast.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Brazil; Chloroquine; Comorbidity; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Parasitemia; Primaquine; Recurrence; Retrospective Studies; Tertiary Care Centers; Thrombocytopenia; Travel; Young Adult | 2014 |
In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Colombia; Drug Resistance; Malaria, Vivax; Mefloquine; Parasitic Sensitivity Tests; Plasmodium vivax; Quinine | 2014 |
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Biological Transport; Child; Chloroquine; Drug Resistance; Erythrocytes; Ethanolamines; Female; Fluorenes; Gene Expression; Haplotypes; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinine; Senegal | 2014 |
Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.
Topics: Amino Acid Sequence; Antimalarials; Artemisinins; Biological Transport; Chloroquine; Chromosomes; Drug Resistance, Multiple; Erythrocytes; Humans; INDEL Mutation; Malaria, Falciparum; Mefloquine; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinolines; Thailand | 2014 |
Studying the effect of chloroquine on sporozoite-induced protection and immune responses in Plasmodium berghei malaria.
Topics: Animals; Antimalarials; CD8-Positive T-Lymphocytes; Chloroquine; Immunity, Cellular; Immunologic Memory; Interferon-gamma; Malaria; Mefloquine; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Plasmodium berghei; Sporozoites | 2015 |
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Cambodia; Chloroquine; Drug Resistance; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Young Adult | 2015 |
In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Epidemiological Monitoring; Ethanolamines; Fluorenes; Gene Dosage; Gene Expression; Genotype; Humans; Kenya; Lumefantrine; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins | 2015 |
In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum.
Topics: Antimalarials; Benzothiazoles; Chloroquine; Diamines; Drug Combinations; Drug Interactions; Erythrocytes; Ethanolamines; Flow Cytometry; Fluorenes; Humans; Lumefantrine; Mefloquine; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Primaquine; Quinolines; Sporozoites; Trophozoites | 2015 |
Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Erythrocytes; Fructose-Bisphosphate Aldolase; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Life Cycle Stages; Malaria, Vivax; Mefloquine; Membrane Transport Proteins; Plasmodium vivax; Protozoan Proteins; Quinolines; Transcription, Genetic; Tubulin | 2016 |
Characterizing Types of Human Mobility to Inform Differential and Targeted Malaria Elimination Strategies in Northeast Cambodia.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Disease Eradication; Health Surveys; Humans; Insect Vectors; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Transients and Migrants | 2015 |
Artemisinin-based combination therapy for knowlesi malaria.
Topics: Antimalarials; Artemisinins; Chloroquine; Female; Humans; Malaria; Male; Mefloquine; Plasmodium knowlesi | 2016 |
An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs.
Topics: Antimalarials; Artemisinins; Artesunate; Benzothiazoles; Child; Child, Preschool; Chloroquine; Diamines; Drug Resistance; Fluorometry; Humans; Inhibitory Concentration 50; Mefloquine; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Staining and Labeling | 2015 |
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
Topics: Antimalarials; Artemisinins; Atovaquone; Benzothiazoles; Biological Assay; Chloroquine; Diamines; DNA, Protozoan; Drug Resistance; Erythrocytes; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Organic Chemicals; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
Topics: Animals; Antimalarials; Artemisinins; Chemoprevention; Chloroquine; Female; Immunization; Malaria; Mefloquine; Mice; Parasite Load; Plasmodium yoelii; Primaquine; Sporozoites; Vaccination | 2016 |
Effect of mild medical hypothermia on in vitro growth of Plasmodium falciparum and the activity of anti-malarial drugs.
Topics: Antimalarials; Artemisinins; Chloroquine; Cold Temperature; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum | 2016 |
Absence of Association between Polymorphisms in the RING E3 Ubiquitin Protein Ligase Gene and Ex Vivo Susceptibility to Conventional Antimalarial Drugs in Plasmodium falciparum Isolates from Dakar, Senegal.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Lumefantrine; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Quinine; Quinolines; Senegal; Ubiquitin-Protein Ligases | 2016 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Thailand; Young Adult | 2017 |
Association between Polymorphisms in the Pf
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asparagine; ATP-Binding Cassette Transporters; Chloroquine; Doxycycline; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Protein Isoforms; Protozoan Proteins; Quinine; Quinolines; Repetitive Sequences, Amino Acid; Senegal | 2017 |
Antibody Responses to
Topics: Adaptive Immunity; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cohort Studies; Disease Resistance; Disease Susceptibility; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Parturition; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Proportional Hazards Models; Risk; Time Factors | 2017 |
Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[ 1,2-a]quinoxalines.
Topics: Amino Alcohols; Animals; Antimalarials; Cell Line, Tumor; Chloroquine; CHO Cells; Cricetulus; Humans; Mefloquine; Plasmodium falciparum; Pyrroles; Quinoxalines; Stereoisomerism | 2018 |
In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine.
Topics: Alkaloids; Antimalarials; Chloroquine; Ethanolamines; Fluorenes; Gametogenesis; Ghana; Humans; Indole Alkaloids; Life Cycle Stages; Lumefantrine; Malaria; Malaria, Falciparum; Mefloquine; Plant Extracts; Plasmodium falciparum; Quinolines | 2017 |
Heterologous Expression of a Novel Drug Transporter from the Malaria Parasite Alters Resistance to Quinoline Antimalarials.
Topics: Amino Acid Transport Systems; Amodiaquine; Animals; Antimalarials; Biological Transport; Chloroquine; Conserved Sequence; Drug Resistance; Gene Expression; Humans; Mefloquine; Mutation; Plasmodium chabaudi; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinine; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Transgenes | 2018 |
Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties.
Topics: Animals; Antimalarials; Bayes Theorem; Chloroquine; Hemeproteins; Humans; Malaria; Mefloquine; Plasmodium falciparum | 2018 |
Topics: Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Atovaquone; Azithromycin; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Humans; India; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2017 |
A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Drug Combinations; Female; Humans; Live Birth; Mefloquine; Middle Aged; Pregnancy; Pregnancy Outcome; Premature Birth; Proguanil; Stillbirth; United States; Young Adult | 2018 |
Nanomolar binding affinity of quinine-based antimalarial compounds by the cocaine-binding aptamer.
Topics: Amodiaquine; Antimalarials; Aptamers, Nucleotide; Binding Sites; Chloroquine; Cocaine; Ligands; Mefloquine; Primaquine; Quinine; Thermodynamics | 2018 |
Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs.
Topics: Antimalarials; Atovaquone; Automation, Laboratory; Chloroquine; Drug Discovery; Hematology; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Schizonts; Trophozoites | 2019 |
Chloroquine and mefloquine resistance profiles are not related to the circumsporozoite protein (CSP) VK210 subtypes in field isolates of Plasmodium vivax from Manaus, Brazilian Amazon.
Topics: Antimalarials; Chloroquine; Genotype; Humans; Malaria, Vivax; Mefloquine; Parasitic Sensitivity Tests; Plasmodium vivax; Polymerase Chain Reaction; Protozoan Proteins | 2019 |
Deployment and Travel Medicine Knowledge, Attitudes, Practices, and Outcomes Study (KAPOS): Malaria Chemoprophylaxis Prescription Patterns in the Military Health System.
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Doxycycline; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Military Medicine; Military Personnel; Practice Patterns, Physicians'; Primaquine; Proguanil; United States; Young Adult | 2020 |
Malaria in the pregnant traveler.
Topics: Antimalarials; Chemoprevention; Chloroquine; Drug Resistance; Female; Humans; Malaria; Mefloquine; Pregnancy; Proguanil; Travel | 2020 |
Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Endemic Diseases; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2020 |
Genetic analysis of the orthologous crt and mdr1 genes in Plasmodium malariae from Thailand and Myanmar.
Topics: Chloroquine; Drug Resistance; Insecticides; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Myanmar; Plasmodium malariae; Polymorphism, Genetic; Protozoan Proteins; Thailand | 2020 |
Comparison of chloroquine-like molecules for lysosomal inhibition and measurement of autophagic flux in the brain.
Topics: Animals; Autophagy; Brain; Chloroquine; Drug Evaluation, Preclinical; Female; HeLa Cells; Humans; Lysosomes; Macrolides; Male; Mefloquine; Mice, Inbred C57BL; Mice, Transgenic; Microtubule-Associated Proteins; Promazine; Quinacrine; Trifluoperazine | 2021 |
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Lumefantrine; Mefloquine; Plasmodium falciparum; Quinine; Uganda | 2021 |
Cryptic Plasmodium inui and Plasmodium fieldi Infections Among Symptomatic Malaria Patients in Thailand.
Topics: Animals; Artemisinins; Chloroquine; Electron Transport Complex IV; Humans; Macaca; Malaria; Mefloquine; Phylogeny; Plasmodium; Plasmodium knowlesi; Retrospective Studies; Thailand | 2022 |
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.
Topics: Adenosine Monophosphate; Alanine; Alveolar Epithelial Cells; Antiviral Agents; Cell Line; Chloroquine; COVID-19 Drug Treatment; Drug Repositioning; Humans; Mefloquine; SARS-CoV-2; Serine Endopeptidases; Virus Internalization | 2022 |
Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Lumefantrine; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Parasites; Plasmodium falciparum; Protein Isoforms; Protozoan Proteins | 2022 |
Opioidergic and nitrergic systems mediate the anticonvulsant effect of mefloquine and chloroquine on seizures induced by pentylenetetrazol and maximal electroshock in mice.
Topics: Animals; Anticonvulsants; Chloroquine; Disease Models, Animal; Electroshock; Mefloquine; Mice; Naltrexone; Nitrites; Pentylenetetrazole; Seizures | 2022 |
Genome-wide functional screening of drug-resistance genes in Plasmodium falciparum.
Topics: Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Protozoan Proteins | 2022 |
Integrative Genetic Manipulation of Plasmodium cynomolgi Reveals Multidrug Resistance-1 Y976F Associated With Increased In Vitro Susceptibility to Mefloquine.
Topics: Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Mefloquine; Plasmodium cynomolgi; Plasmodium falciparum; Plasmodium vivax | 2023 |